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Abstract
Each year millions of people face the medical decision-making cycle that comes with a
diagnosis of cancer. For patients and their families, this can be a rollercoaster of
confusion and fear. Researchers have indicated that the complexity of the decisionmaking process is underrepresented in the current approach of informed decision-making.
The purpose of this study was to add to scientifically-validated research expanding the
identification of factors that influence decision-making for individuals diagnosed with
cancer. Fuzzy trace theory (FTT) is the dual process memory theory used as the
framework for this study. Qualitative data were collected using semistructured interviews
with 10 participants. The sampling strategy included purposeful sampling and snowball
or chain sampling. The audio-recorded interviews were transcribed and analyzed.
Software tools were used to aid in the creation of word mapping and clusters and a
naming structure emerged. A comprehensive thematic analysis was completed.
Participants detailed experiences with family and social dynamics, psychological or
emotional stress, external influencing factors to the decision-making process, and
experiences with cancer advertising. This research can create positive social change
through the advancement of scientifically-validated research to support patients during
the decision-making process.
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Chapter 1: Introduction to the Study
According to the National Cancer Institute (NCI, 2017), 14.5 million individuals
in the United States live beyond a diagnosis of a cancer. Cancer survivors face multiple
medical decisions throughout their journey. Treatment options continue to change with
advances in scientific discoveries and technology (American Society of Clinical
Oncology [ASCO], 2015). Examples of advances in the treatment of cancer include
improvements and developments in surgical technique, increased systemic drug
regimens, expansion of genetic testing, and greater applications of radiation therapy in all
stages of disease (Masters et al., 2015). With numerous treatment advances, individuals
face increasingly complex treatment decision-making (ASCO, 2015; Croyle, 2015;
Reyna, Nelson, Han, & Pignone, 2015).
Continued expansion and complexity in medical options can influence patient
informed decision-making (Reyna et al., 2015). Wolfe et al. (2015) suggested complex
treatment options and limited time between diagnosis and treatment could result in poor
decision-making practices by patients. Informed decision-making requires the ability to
ascertain “benefits, risks, and uncertainties,” in addition to incorporating personal
preference and desired control (Reyna et al., 2015, p. 105). The emotional and cognitive
environment that exists parallel to personal preference and desired control is equally
complex, and the influence is less tested with scientific rigor (Aning, Wassersug, &
Goldenberg, 2012; Bodie et al., 2011; Epstein & Gramling, 2013; Reyna et al., 2015).
Numerous internal and external influencers further complicate patient decision-making at
a time when stress and fear levels have increased.

2
In the next section, I provide the study background based on literature review
findings, followed by the problem statement, purpose, and framework. Study details
including methodology, sources of data, limitations, and assumptions, are also provided. I
provide the study significance and summary in the final portions of this chapter.
Background
I reviewed many articles specific to shared decision-making (SDM), provider
communication, messaging, and patient-directed care. I identified degrees of discordance
in the research conclusions in each area in the literature review. However, the influence
of provider messaging in the decision-making process was underrepresented in the
literature. Researchers have also found variations between patients deferring all decisionmaking to their providers to examples of patients preferring to make all treatment
decisions and areas in-between (Back, Trinidad, Hopley, & Edwards, 2014; Epstein &
Gramling, 2013; Livaudais, Franco, Fei, & Bickell, 2013; Pass, Belkora, Moore, Volz, &
Sepucha, 2012, Singh et al., 2010).
I could not identify scholarly publications that showed causation of compliance or
nonadherence with treatment. Perceived confidence by patients in decision-making was
identified as represented in the literature (Aneja & Yu, 2012; Epstein & Gramling, 2013;
Forsythe et al., 2014; Glass et al., 2012; Reyna et al., 2015). Understanding the role of
patient specific exposures to variables that influenced decision-making was considered
important to support healthcare providers in meeting the expectations for informed
consent and SDM.
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I also reviewed reports from leading organizations in healthcare and reports of
cancer care practice trends in the United States. The criteria I reviewed, in the annual
reports by ASCO (2015) and Institute of Medicine (IOM, 2013), were broad and included
areas beyond the scope of this research. The ASCO (2015) and IOM (2013) reports
indicated rich details about industry shortcomings and the need for improvements in
patient/provider communication. The reports oversimplified the healthcare delivery
environment and lacked a direct correlation or causal factors for the identified gaps in this
research. The ASCO (2015) and IOM (2013) reports supported this research study in at
least two distinct ways. First, many references to cancer treatment decision-making and
disruptions in cohesive care were cited. Second, the ASCO (2015) and IOM (2013)
reports highlighted the need to identify and define causal factors and opportunities for
improving the patient decision-making experience.
Next, I observed limited research regarding the influence of messaging by
members within the patients’ support circles or other external influences. Some
researchers mentioned various external influences and suggested additional study in this
area (Epstein & Gramling, 2013; Forsythe et al., 2014; Imber-Black, 2014). The lack of
in-depth study, regarding the influence of external influencing factors on decisionmaking, was important for this study.
In addition, the role of psychological distance was found as very new in the
literature and should be further reviewed in the setting of cancer decision-making
(Fukukura, Ferguson, & Fujita, 2013; Reyna et al., 2015). Fukukura et al. (2013)
suggested that the decision-making process was improved when sufficient time could
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elapse during situations where a great deal of information was presented. I identified no
researchers who addressed psychological distance related to cancer treatment decisionmaking.
The use of decision-making aids for patients diagnosed with cancer was
inconsistent in the many examples of literature I reviewed (IOM, 2013; Joseph-Williams,
Elwyn, & Edwards, 2014; Reyna et al., 2015; Thorne, Oliffe, Stajduhar, Oglov et al.,
2013). In addition, the influence of expanded Internet-based education tools was
introduced but not in depth (Wolfe et al., 2015). Wolfe et al. (2015) suggested decisionmaking tools or aides were not based on medical decision-making theories; as such, these
were not as effective as possible. For this reason, I believed this represented an area that
warranted further study.
I found limited research on the influence of marketing techniques from direct to
consumer advertising (DTCA) during treatment decision-making (Abel, Burstein,
Hevelone, & Weeks, 2009; Tan, 2015; Vater et al., 2014). Increased competition between
healthcare organizations and continued changes in reimbursement have escalated the
need for organizations to solicit patients to seek services at their facilities. The gaps in the
current literature on DTCA was suggested as an important area for additional research
specific to influence on the decision-making process.
Researchers have identified the role of dual process decision-making in health
care and noted it as an area in need of additional study attention (Reyna et al., 2015;
Wolfe et al., 2015). The literature included descriptions of the confused mental state that
could accompany a diagnosis of cancer (Wolfe et al., 2015). Reyna et al. (2015) also
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recommended future research aimed at understanding ways in which individuals
organize, synthesize, and recall information for cancer treatment decision-making. In
addition, I evaluated how to ensure providers addressed personal values, external
messaging, and other factors that influenced decision-making.
Problem Statement
Researchers have identified needs for greater understanding of the relationship
between emotion and cognition, as well as ways in which the dual process theory have
influenced decision-making (Fukukura et al., 2013; Reyna et al., 2015). Cleary defined
variables, related to emotion and cognition for patients faced with a diagnosis of cancer,
were limited in the literature and have potential implications on informed decisionmaking (Livaudais et al., 2013; Reyna, 2012; Reyna et al., 2015). I reviewed literature
that indicated discordance in study conclusions about informational needs for patients
during decision-making. Based on gaps in the literature review findings, further
evaluation was needed to understand the influence of emotionally-based appeals used in
DTCA on cancer treatment decision-making (Abel et al., 2009; Tan, 2015; Vater et al.,
2014).
Purpose
The purpose of this study was to gather detailed interview responses, analyze and
interpret the data, and develop recommendations for understanding the treatment
decision-making process. In this study, I focused on understanding the influence of the
identified variables on gist and verbatim recall, as well as the influence on patients during
dual process decision-making. Verbatim recall refers to detailed and “precise
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information,” while gist recall refers to “meanings” that are unique to individuals (Smith
et al., 2013, p. 6189). Verbatim and gist are discussed in greater detail in subsequent
sections.
Research Questions
Research Question 1: What are the information-based (verbatim) factors
influencing cancer treatment decision-making for patients diagnosed with cancer?
Research Question 2: What are the emotional-based (gist) factors influencing
cancer treatment decision-making for patients diagnosed with cancer?
Research Question 3: Are there factors outside of verbatim or gist examples that
are reported as influential in the cancer treatment decision-making process in the study
population?
Theoretical Framework
Health care decision-making literature included the theoretical framework of dual
process, cognition, and emotion. According to Reyna et al. (2015), FTT includes
verbatim and gist recall. Verbatim recall, relating to cancer treatment decision-making,
consists of complex concepts (e.g., survival or risk ratios and efficacy percentages; Reyna
et al., 2015; Wolfe et al., 2015). Gist recall includes the “fuzzy” portion of decisionmaking based on unconscious awareness or individual perception (Reyna et al., 2015).
The focus of this study was on the relationship between factual and emotional navigation
through the decision-making process and understanding how each category influences
decision-making.

7
Nature of the Study
I chose case study design for my qualitative research, and I focused on developing
answers to explain the defined research questions, as suggested by researchers (Center for
Research Quality, 2015; Maxwell, 2013; Patton, 2015). The key phenomenon was the
decision-making experience for patients newly diagnosed with cancer. I selected case
study for the unique properties of this method. According to Creswell (2013), case study
seeks to gather in-depth understanding about real-life cases being studied. Merriam
(1998) described case study as a “holistic description” (p. 20). Case study is also useful
for the development of themes (Creswell, 2013). In this research, I included the multiple
case study approach and employed replicated interviews to assist in generalizing the
findings (see Creswell, 2013).
Two sources of data collection were used in the completion of this research.
Participant data were collected using (a) semistructured in-depth interviews and (b)
follow-up calls. Participant data were transcribed and hand coded with the creation of a
naming structure for thematic analysis. The second data source included cancer center
advertising materials. I reviewed website data advertisements for facilities in California.
The secondary data were evaluated using some of the key terms identified during the
literature on DTCA (Abel et al., 2009; Tan, 2015; Vater et al., 2014).
Definition of Terms
Cancer: Cancer is the uncontrolled growth of abnormal cells (National Institutes
of Health, 2015b).
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Diagnosis: Diagnosis is the clinicians statement of disease or condition after
evaluating the symptoms, physical exam, and findings from testing (National Institutes of
Health, 2015b).
Direct-to-consumer-advertising (DTCA): DTCA refers to patient directed
advertising is usually associated with pharmaceuticals but is also used to describe other to
include direct advertising for medical treatment to specific populations (Tan, 2015).
Gist recall: As used in FTT, gist recall refers to the substance, essence, or
meaning of an encounter or experience (Reyna & Brainerd, 1995).
Primary site: The primary site is the location where the cancer started, which is
usually named after the organ where the cancer originated or started (National Institutes
of Health, 2015b).
Stage: Stage refers to the schema used to detail how far the cancer has spread and
is based on defined criteria (National Institutes of Health, 2015a).
Verbatim recall: As used in FTT, verbatim recall refers to the recollection of
detail that includes literal fact or very specific details (Reyna, Nelson, Han, &
Dieckmann, 2009).
Assumptions
The assumptions that guided this study included that (a) the patient/provider
relationships are more complex than reflected in the literature; (b) DTCA provides a
greater influence on patient decision-making compared to what is currently understood;
(c) the patient support circle provides greater influence on decision-making compared to
what is currently understood; (d) semistructured in-depth interviews, completed as close
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to the first date of diagnosis as possible, provided the best opportunity for accurate
memory recall; and (e) participant enrollment could be challenging close to the delivery
of a diagnosis due to the life changes associated with a life threating illness.
Scope and Delimitations
The scope of the study included patients facing a first diagnosis of cancer with no
limitations from stage of disease or primary site. I did not include participants with a
previous diagnosis of cancer. Additional eligibility requirements included being between
the ages 25 to 80, being without cognitive impairment, and living in California at the time
of diagnosis. I used a qualitative approach to evaluate the influence of emotion and
cognition for patients during the decision-making process. I identified the variables
specific to decision-making in this population in the literature review and integrated these
into the research design and interview questions. I combined participant data and data
from the literature and document review. I conducted interviews in person, without the
use of external interviewers. Telephone interviews were used for participants who could
not keep an in-person interview.
Limitations
The study included only individuals living in the state of California at the time of
diagnosis. The focus on participants from a specific state could limit the ability to
generalize the analysis findings to the broader public. The accuracy of self-reported
information from interviewees might also represent a limitation due to recall bias or
confirmation bias. Another limitation was the criteria of English speaking only
participants. According to the U.S. Census Bureau, several cities within California have
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large populations where languages other than English are spoken at home
(http://www.census.gov). Due to limited resources for interpretation of materials and
transcribing, I only enrolled English-speaking participants. Interviewers can also be a
limitation if interviewer bias or emotions are not separated from the study process
(Patton, 2015). Staying mindful development and review of all study and interviewing
materials helped limit interviewer bias. Understanding potential pitfalls and incorporating
stop gaps into the study design was met. For instance, confirmation bias was noted to
effect memory impacting recall of information, as suggested by researchers (Frost et al.,
2015). The use of vocal recording and verbatim transcription reduced the potential for
confirmation bias in the capture and analysis of interview content.
Significance of Study
This research could expand theory-based findings regarding patient/provider
communication and shared decision-making. The study findings were significant for
provider practices by offering a better understanding of the variables that have the
potential to influence patients during cancer treatment decision-making. This study
showed practitioners opportunities for a deeper understanding of patients’ needs during
the decision-making process. In addition, this study could allow for the development of
best practices for shared decision-making focused on patients’ reported needs.
This research was also important to understand further the theoretical constructs
of dual process cognition and emotion during the decision-making process for patients
confronted with a diagnosis of cancer. Specifically, this study indicated a better
understanding of the roles of verbatim and gist recall in situations of life threatening

11
illness. Study findings would allow for continued growth in the fields associated with
decision-making and health behavior.
The positive social change influence of this research included developing
processes to support individual patient preferences for cancer treatment. Cancer patients,
the oncology health care community, and health care leaders could use the research
findings for clinical and programmatic strategies that focused on blending scientific
advancements and patient preference.
Summary and Transition
Specialty providers have faced delivering the diagnosis of cancer to vast numbers
of patients every year. The study purpose focused on understanding internal and external
variables that influenced decision-making for patients diagnosed with cancer. I
considered comprehensive theory-based research analysis of the patient decision-making
process lacking. In addition, conflicting literature findings on components of this research
added to the support for further study. The journey of patients diagnosed with cancer and
their support system could involve fear, anxiety, and unknown outcomes. Patients face
influencing variables from many directions. The theoretical framework of FTT and dual
process decision-making provided the correct approach for this research.
Chapter 2 details the findings of the literature and various research elements.
Chapter 3 follows with detailed research methods. Chapter 4 presents the findings from
this research. Finally, Chapter 5 concludes the study with implications, recommendations,
and a final summary.
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Chapter 2: Literature Review
Introduction
The IOM (2013) stated, “Patient-centered communication and shared decisionmaking” (p. 20) was lacking in the United States. The IOM (2013) suggested treatment of
decision-making was often not evidence based and that physician practices lacked
standardized methods to address this challenge. Several researchers have indicated other
variables or influencing factors could be responsible for challenges in the shared
decision-making process for patients diagnosed with cancer (Epstein & Gramling, 2013;
Forsythe et al., 2014; Imber-Black, 2014). The assessment of patient/provider
relationships, shared decision-making, and identification of patient preferences was
warranted to ensure clinicians met the needs of patients and their support systems.
In addition, I identified the emerging field of psycho-oncology and the challenges
in sharing complex medical information with patients. Research in understanding
effective approaches to presenting complex medical information provided opportunities
to clarify the needs of patients during the decision-making processes. Progressive
research on dual-process decision-making theories would provide explanations for use in
patient/provider relationships. Identifying and understanding factors that influenced
decision-making was suggested as important for the adequate evaluation of this topic.
Family influence and consumer advertising represented examples of potential influencing
factors that researchers did not explain with great depth in the literature.
This chapter includes an introduction to FTT, the theoretical framework of this
study. The next section includes an outline of multiple variables or influencers identified
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in the literature. Variables/influencing factors included (a) decision-making elements; (b)
provider specific variables; (c) the patient/provider relationship; (d) provider
communication and shared decision-making; (e) patient specific variables; (f) patient
preference; (g) family and social direction; (h) faith, spirituality, or personal belief
variables; (i) ethnic, cultural, and individual views; (j) other individual characteristic
variables; (k) and DTCA. In the next section, I detail dual process cognition and emotion,
verbatim and gist memory, and psychological distance.
Literature Search Strategy
Search Strategy
I conducted the literature review by searching multiple databases. I used
MEDLINE and CINAHL as the primary databases. I used SocINDEX, ProQuest,
PubMed, and SAGE for literature searches. Additional industry specific databases
searched included the American Cancer Society (ACS, 2016) and the NCI (2017)
division of the National Institutes of Health (2015a, 2015b).
Search Terms
Primary search terms included cancer, dual cognition, dual-process, emotion,
decision-making, cancer treatment, patient/physician relationship, and fuzzy trace theory.
I used additional terms in combination with the primary search terms that included
literacy, numeracy, informed consent, and quality.
Theoretical Framework
I used FTT as the theoretical framework in this study. According to Reyna and
Brainerd (1995), the development of FTT began in the early 1990s, detailing human
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reasoning, memory, and disassociation. FTT evolved based on continued research
findings in the field of memory and logic (Reyna & Brainerd, 1991). Psycholinguistics
was also referenced for the associations with FTT (Reyna, 2012). According to Reyna
(2012), FTT has undergone many phases of research testing.
Verbatim and gist recall are the dual processes associated with FTT and were the
focus in this literature review. Verbatim recall is based primarily on detailed information
or complex facts, and gist recall is based primarily on emotion (Reyna, 2012; Reyna et
al., 2015). The processes of emotion and cognition occur in many possible sequences, in
tandem, separate, interrupted, or dependent, and these are unique to each cancer patient’s
journey. Reyna (2012) added a third FTT theme, intuition, and suggested an overlapping
of decision-making. This theme is covered in greater detail in the section on dual-process
cognition and emotion. FTT is used in most of the remainder of this study. Occasionally,
dual process is used when speaking of decision-making theories in general. When
referring to a specific memory recall, verbatim or gist is used.
According to Reyna (2008), distraction occurs more often in verbatim memory
compared to with gist memory. An increase in distraction during verbatim recall can
influence decrease decision-making based on science and shift greater emphasis on
emotional recall. I will explain the influence of verbatim and gist recall in greater detail
later in this chapter.
The selection of FTT as the theoretical framework was based on the culmination
of advances in the development of FTT. The 2015 publication in American Psychologist
highlighted many components of decision-making that occurred throughout the cancer
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journey (Reyna et al., 2015). Reyna et al. (2015) presented multiple components of
memory recall involved during decision-making. The authors also detailed the expansion
of FTT, applicability of FTT, and specificity to cancer decision-making. After conducting
research in FTT from the early literature through current writings, the use of FTT as the
theoretical approach was solidified.
Literature Review
Decision-Making Elements and Variables
Decisions, made in response to a diagnosis of cancer, can be complex and
overwhelming (Epstein & Gramling, 2013; Gibbins, Bhatia, Forbes, & Reid, 2014).
Epstein and Gramling (2013) defined cancer decision-making as an iterative process, an
excellent description for a period often rife with emotion and decision-making starts and
stops. In this research, I focused on provider specific, patient specific, and other external
variables or influencing factors related to decision-making after a diagnosis of cancer.
Decision-making elements for patients diagnosed with cancer vary based on their
individual cancer types and the extent of disease. The completion of additional testing
may occur to establish a clearer understanding of the extent of disease before forming a
treatment plan (IOM, 2013). The current health status of the patient is also an element
one must consider (IOM, 2013). Surgery, chemotherapy, radiation therapy,
immunotherapy, targeted therapies, and hormone therapy entail the most common
modalities of treatment for cancer (National Institutes of Health, 2015a). Types of
treatment are also unique to each person’s journey. The elements detailed play only a
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minor role in this research. In the next section, I provide greater detail of the focus of this
research.
Variables support, change, or otherwise can influence patient decisions and exist
in combination with the elements of their diagnosis (Bodie et al., 2011). Variables are
unique to each patient and occur at multiple points throughout the journey. The
subsequent sections include the literature review findings, as outlined in the following
categories: (a) provider specific variables, (b) patient specific variables, and (c) other
external influences. Each category has prominent subcategories that I identified during
the literature review.
Provider Specific Variables
I identified key provider specific variable terms in the literature that showed
support for an evolution toward care models that focused on partnerships between
providers and patients. Terms, such as patient-centered, shared decision-making, and
patient-driven care models, were prominent. Researchers have noted important factors
about the patient/provider relationship and provider communication, which indicated a
need for greater study (ACS, 2016; ASCO, 2015; Epstein & Gramling, 2013).
Patient/provider relationship. The development of the patient-provider
relationship can influence the decision-making process (Epstein & Gramling, 2013). In
the management and treatment of life-threatening chronic illness, as in the instance of
cancer, emotions, and external influences, can also influence the patient-provider
relationship (Epstein & Gramling, 2013). All patients, diagnosed with cancer, and their
support systems have a unique set of needs and expectations of their providers (Dy et al.,
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2014). Specialty oncology physicians often meet patients for the first time at the initial
diagnosis or shortly after. Only a small window of time is left to quickly understand the
“unique characteristics of each clinical situation” (Epstein & Gramling, 2013, p. 97S).
A medical oncologist often manages the cancer care plan. With continued changes
in health care environments and reimbursement, medical management can vary
(Friedman et al., 2014). Patients may have relationships with many specialty physicians,
at multiple facilities, and in some instances, in different geographic areas, increasing the
potential for missed communication during the continuum of care (ASCO, 2015). The
IOM (2013) and the ASCO (2014, 2015) published articles in support of team-based
models and multidisciplinary teams, as methods to ensure comprehensive input for
treatment considerations (Friedman et al., 2014).
Providers must deliver the information needed during decision-making in a
situation that is often complex and ambiguous (Epstein & Gramling, 2013; JosephWilliams et al., 2014). How the information is delivered and by whom are important to
consider (Epstein & Gramling, 2013; Joseph-Williams et al., 2014). Joseph-Williams et
al. (2014) offered a systematic analysis of nearly 300 articles, detailing the complexity of
the exchange of information during the decision-making process. The provider skill in
messaging was an important factor in the patient-provider relationship (Joseph-Williams
et al., 2014). Joseph-Williams et al. (2014) pointed out that finding a balance in
messaging and fostering an effective patient/provider relationship was complicated but
not insurmountable (Thorne, Oliffe, Stajduhar, Oglov et al., 2013).
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Provider communication and shared decision-making. SDM is an approach
focused on defining patient preference and incorporating that preference into the
treatment decisions (Clayman, Makoul, Harper, Koby, & Williams, 2012; Glass et al.,
2012; Pass et al., 2012). Specifics about the benefits of SDM varied in the literature.
Transparency, open discussions, and sharing of all treatment options is the gold standard
in cancer care (Housri, Coombs, Orandi, Pawlik, & Koniaris, 2011).
Glass et al. (2012) surveyed 488 individuals, aged 21 to 70, with various health
decision-making interactions. Glass et al. focused on understanding the relationship
between SDM and patient satisfaction. Glass et al. provided specific areas of focus that
complemented my research. For instance, the SDM-Q-9 questions were specific to
defining the interaction between the patient and the provider, representing the basis of
SDM (Glass et al., 2012). In this study, I identified the presence of SDM for participants
and expanded the understanding of variables that influenced SDM for participants.
Patients and their families need provider, as it can influence patient decisionmaking behaviors. Some researchers have suggested that communication needs differed
when patients were newly diagnosed or further along in their cancer journeys (Back et al.,
2014; Thorne, Oliffe, & Stajduhar, 2013). Knowing what the patient needs to or wants to
hear is complex. Whether using SDM, meaningful participation, or another
communication technique, each patient has a distinctive set of needs and expectations
(Epstein & Gramling, 2013).
I also identified research that addressed provider skills in the delivery of
diagnoses and decision-making information in an SDM format (Joseph-Williams et al.,
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2014; Pass et al., 2012). Some researchers have suggested physicians lacked training in
the technique of SDM or had limited skills in tailoring messaging for patients (Livaudais
et al., 2013; Pass et al., 2012). Epstein and Gramling (2013) claimed that the complexity
of messaging compounded the other challenges in communication. Glouberman and
Zimmerman (as cited by Epstein & Gramling, 2013, p. 96S) asserted that problems arose
when providers addressed complex situations with simplistic approaches. Some
researchers have suggested providers should use less complicated messaging to help
patients better understand the diagnosis and treatment, which would lead to better patient
compliance (daCosta DiBonaventura, Copher, Basutro, Faria, & Lorenzo, 2014).
Researchers have noted the potential for providers to persuade or otherwise
influence patients due to framing during the process of messaging (Broniatowski &
Reyna, 2013; Epstein & Gramling, 2013; Reyna & Brainerd, 1991). For the purposes of
provider messaging, review of the literature indicated framing influenced patient
decision-making, even to the point of going against their own preferences (Back et al.,
2014; Epstein & Gramling, 2013). Framing by providers is composed of all portions of
the messaging, such as scientific data, recommendations, biases, or past experiences.
Pass et al. (2012) recorded SDM exchanges between patients and providers. The
study consisted of medical record review, surveys, and observations. A total of 178
patients participated in the study. Pass et al. stated participants reported they used all
SDM activities. Pass et al. also suggested that patient ratings, compared to observer
ratings, indicated patients gave providers higher ratings for exhibiting SDM behaviors.
According to Pass et al., patients scored physicians high for making them feel involved in
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the decision-making process but not as high for seeking their preferences. Conversely, the
nonpatient observers gave the physicians high marks for preference seeking (Pass et al.,
2012). The difference in perception, presented in this study, underscored the complexity
that providers and patients faced in the delivery and receiving of a diagnosis of cancer in
a format that they could use.
There is no defined time when patients are most open to receiving a diagnosis of
cancer (Epstein & Gramling, 2013; Thorne, Oliffe, & Stajduhar, 2013). Patients are not
always adequately prepared to receive, process, and make decisions related to a cancer
diagnosis, at least in the early stages (Back et al., 2014; Livaudais et al., 2013; Thorne,
Oliffe, Stajduhar, Oglov et al., 2013). In addition, not all patients are comfortable with
the responsibility of decision-making and may feel overwhelmed or burdened by the
responsibility (Back et al., 2014; Livaudais et al., 2013; Pass et al., 2012). Back et al.
(2014) suggested patients did not want to define personal treatment goals, as suggested in
other literature. There are varying levels of desired participation by patients in treatment
decision-making, requiring physicians to identify this issue, as well as other
characteristics early in the patient/provider relationship (Epstein & Gramling, 2013;
Hauer, Fernandez, Teherani, Boscardin, & Saba, 2010; Livaudais et al., 2013; Pass et al.,
2012; Singh et al., 2010). Delivering the diagnosis and treatment information in an SDM
format may provide patients with the peace of mind of having heard everything, even if
they defer to the provider for final decision-making (Shay & Lafata, 2015).
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Patient Specific Variables
In this section, I detail patient specific variables, identified in the literature
review, that exist in combinations with the patient/provider relationship. Many
nonclinical influencing factors are identified that patients must navigate throughout their
journey. The influence of each of these variables on decision-making is important to
understand.
Patient preference. A new diagnosis of cancer presents patients with an
unfamiliar situation (Epstein & Gramling, 2013). Patients may not easily express their
preferences due to the confusion, anxiety, and emotions that accompany a diagnosis of
cancer (Epstein & Gramling, 2013; Jager, 2012). Glass et al. (2012) suggested patients
reported higher levels of satisfaction when their preferences were discussed with provider
recommendations in an SDM format. People are not good at identifying their own
preferences when faced with areas of unknown information (Reyna et al., 2015). Reyna et
al. (2015) claimed the ambiguity of treatment information, such as statistical values
associated with the complexity of treatment efficacy rates, was an example where
patients could face difficulty in identifying their own preferences. In the section on
verbatim and gist, I provide important factors of the decision-making process found in the
literature, along with further correlation between patient preference and SDM.
In addition, the results in the literature have shown patients would accept potential
side-effects or long-term post-surgical effects of treatment if their perception included the
belief that all risks were acceptable (daCosta DiBonaventura et al., 2014; Gibbins et al.,
2014). Gibbins et al. (2014) produced findings that patients used criteria related to ways
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in which treatment would influence their daily living as a deciding factor for accepting or
declining treatment. Other research findings have shown patients are willing to endure
extensive side-effects and high costs in the hopes for a cure (daCosta DiBonaventura et
al., 2014). Conversely, as mentioned in the previous section, many patients prefer not to
have the responsibility of treatment decisions (Back et al., 2014; Livaudais et al., 2013;
Pass et al., 2012)
Family and social direction. Imber-Black (2014) highlighted influence from
family and social relationships during the treatment decision-making process. They
furthered that families could be ill-equipped to have discussions related to chronic lifethreatening illness; in some instances, the family discussions could cause more harm
(Imber-Black, 2014). Imber-Black (2014) provided clinical exemplars (real patient
stories) to demonstrate the complexity and influence of families on patients faced with
chronic illness. In addition, Imber-Black indicated that the delivery of a diagnosis of
cancer could bring to the surface old and hidden away memories.
I observed examples of the social influence from mainstream publications on
decision-making. For instance, on a large scale, the “Angelina Jolie effect” is a prime
example of mass media and fame influencing public awareness and medical decisionmaking (Lebo, Quehenberger, Kamolz, & Lumenta, 2015). Several editorials were
written after Ms. Jolie went public with her decision to have a prophylactic double
mastectomy in response to a positive BRCA genetic test. Spikes in genetic screening and
mastectomies were reported, with decreases in both after time passed.
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On a smaller scale, some research findings have indicated social influence could
occur from interactions with friends, groups, and other social circles (Bodie et al., 2011).
Bodie et al. (2011) suggested individuals under great stress would seek social support.
Framing, as explained in the previous section, can also occur in family and social
interactions. Bodie et al. (2011) and Imber-Black (2014) suggested “supportive
communication” was not always pertinent to the individual’s diagnosis, and it might even
be harmful. Imber-Black (2014) detailed the influence of the patient’s past experiences
with cancer in others and of those experiences on the patient’s decisions. From another
perspective, Epstein and Gramling (2013) indicated that social influence could help the
patient feel a greater sense of “autonomy.”
Faith, spirituality, or personal belief variables. Newfound spirituality or
strengthening of current faith and spirituality after a diagnosis of cancer were well
established in the literature (Burg et al., 2015; Lagman, Yoo, Levine, Donnell, & Lim,
2012; Stanton, Rowland, & Ganz, 2015; Tallman, 2013). I identified limited research
regarding the influence of faith and spirituality on cancer treatment decisions. Faith,
words of hope, and other spiritually-charged experiences were prominent in the literature
for patients facing a diagnosis of cancer (Back et al., 2014; Schapmire, Head, & Faul,
2012). Patients who have strong faith or spiritual beliefs were described as having a sense
that things would work out as planned (Drew & Schoenberg, 2011; Schapmire et al.,
2012). Researchers have also noted faith and spirituality in treatment decision-making
could extend to alternative options, such as faith healers (Lagman et al., 2012).
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Ethnic, cultural, and individual views. The influence of ethnicity on cancer
treatment decision-making was not clearly defined during the literature review. I
identified research that reflected higher rates of disease, more advanced disease at
diagnosis, and decreased use of screening methods within certain ethnic groups (IOM,
2013). Livaudais et al. (2013) included a longitudinal review of 368 women, ages 28 to
89, who were treated for breast cancer. Livaudais et al. suggested ethnicity influenced
decision-making in two ways: increased mistrust of the medical profession and decreased
desire to make then medical decisions. Livaudais et al. suggested underlying cultural
differences as the reason for variations in the patient report decision-making roles
Huang, Ma, Ngo, and Rhoads (2013) researched the use of NCI (2017) designated
facilities with defined populations. Huang et al. (2013) suggested there were variances in
the use of NCI (2012) facilities by minority groups. Huang et al. included the review of
79,231 records from the California Cancer Registry of patients diagnosed and treated
1996 through 2006. The interpreted findings showed monitories were less likely to use
NCI (2012) facilities; researchers have noted the living distance from and NCI (2012)
facility as a key predictor to limiting use (Huang et al., 2013).
Joseph-Williams et al. (2014) indicated higher rates of deferring to authority by at
least one minority group. Singh et al. (2010) stated non-White minority populations in the
study were younger in age compared to Whites. In addition, Joseph-Williams et al.
(2014) suggested that younger participants wanted to take a more active role in medical
decision-making. It was yet to be seen if younger ethnically diverse people would take
the role of active shared decision maker.
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Other Individual Characteristic Variables
What patients received from message exchanges varied based on the individual
receiving the information (Thorne, Oliffe, & Stajduhar, 2013). Researchers have noted
characteristics, such as age, language, economic factors, or literacy and education, as
influencing medical decision-making. Literature findings, specific to the aforementioned
characteristics, were sparsely represented and presented in the subsequent paragraphs.
Cohen, Jenkins, Holston, and Carlson (2013) identified factors, such as age,
geography, and socio-economic status, played a role in medical decision-making.
Researchers have associated age with desiring a more active role in decision-making
(Singh et al., 2010). Aneja and Yu (2012) and Lin et al. (2016) suggested geography
represented an influencing factor for deciding to leave a community to receive specialty
care or to forgo treatment due to the distance. Huang et al. (2014) suggested higher
education rates were equivalent to higher rates of NCI (2012) facility use. Huang et al.
noted socioeconomic factors as associated with influencing the selection of where to
receive treatment.
Researchers have suggested numeracy as relational to the understanding of
numerical data, which was not an effective method of communication in medical
decision-making (Rabin & Glasgow, 2015; Reyna et al., 2015). The cancer stage is a
numerical schema that details how far the cancer has spread at the time of diagnosis
(http://www.cancerstaging.org). Treatment efficacy and survival rates are also numeric
values, reflected most often in percentages (Reyna et al., 2009). Reyna et al. (2009)
suggested challenges with numerical data existed even for individuals in the health field
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with an extensive education. Reyna et al. (2015) indicated increases in decision-making
fluctuation when low numeracy was present. Given the prevalence of numerical data
associated with cancer decision-making and the suggestions that patients struggle with
complete understanding, it is probable that challenges will arise during decision-making.
I observed indications in literature review findings that suggested the timing of
serious illness can influence decision-making (Imber-Black, 2014). For instance, patients
might be experiencing the anniversary of the death of a loved one at the time of their
diagnosis and have an emotional response to their own decision-making. A discussion on
timing is also included in the later section on psychological distance.
Researchers have mentioned the use of decision-making aids as both effective and
ineffective in the literature (IOM, 2013; Joseph-Williams et al., 2014; Reyna et al., 2015;
Thorne, Oliffe, Stajduhar, Oglov et al., 2013). The IOM (2013) suggested decisionmaking aids were beneficial for providing decision-making education to patients, but
these fell short in some areas, such as how to navigate an SDM encounter with a provider
(Epstein & Gramling, 2013; Joseph-Williams et al., 2014). Rabin and Glasgow (2015)
provided a review of the literature that assessed gaps related to the development and use
of cancer specific noncomplex information for patients. In addition, daCosta
DiBonaventura et al. (2014) supported previous research and suggested benefits in using
less complicated treatment regimen information. Finally, Lillie et al. (2014) suggested
decision-making aids were less effective when used only with the patient, without their
support member or members present.
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Direct-To-Consumer-Advertising (DTCA)
The final external variable I included as pertinent to the current research was
Direct-To-Consumer-Advertising (DCTA). The literature review on DTCA was limited. I
reviewed and included Abel et al.’s (2009) older study in the literature review to
understand the influence of DTCA, which involved reviewing the advertising method,
exposure, and messaging. Each study, published on this topic, approached DTCA in a
different fashion; these are detailed in the following paragraphs.
According to Tan (2015), DTCA is controversial primarily due to the complexity
of cancer treatments and the cost associated with care. Researchers have noted
advertising for health care services as lacking the heavy regulatory oversights placed on
pharmaceuticals ads (Schenker, Arnold, & London, 2014). Schenker et al. (2014),
suggested the lack of regulatory oversight allowed companies to advertise without
accountability.
Tan (2015) focused on DTCA from the population level for breast, prostate, and
colorectal cancers. Tan also suggested that age and ethnicity played a factor in the
number of reported exposures to DTCA. Participants in the Tan research reported less
frequency in exposure to DTCA with increased age. The exposure to DTCA, based on
ethnicity, included African Americans reporting higher exposure to DTCA for prostate
cancer, and Hispanics reporting higher rates of colorectal cancer DTCA over their White
counterparts (Tan, 2015). Tan (2015) stated the highest reporting of DTCA was in breast
cancer patients.
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The systematic content analysis, conducted by Vater et al. (2014), included a
review of 409 messages from 102 cancer centers. Vater et al. suggested advertising
content included emotional messaging to influence the decision-making of patients.
Researcher have also used framing in DTCA to prime recipients to receive specific
messaging (Broniatowski & Reyna, 2013; Epstein & Gramling, 2013; Reyna & Brainerd,
1991). In addition, limited information, regarding risk or treatment efficacy, appeared in
the advertising, and researchers reported the use of emotional messaging and phrases of
hope as the centerpiece of DTCA (Vater et al., 2014).
Abel et al. (2009) included surveys from 348 individuals with a diagnosis of
breast or blood cancers and under treatment at the Dana-Farber Cancer Center in Boston,
MA. A high number of the participants responded that they were aware of and exposed to
DTCA within the preceding 12 months (Abel et al., 2009). Television was the primary
source of DTCA exposure, and most participants stated they became aware of treatments
they did not previously know about (Abel et al., 2009). Most participants agreed the
messaging used was easy to understand, and participants reported feeling positive about
the impact of the messaging (Abel et al., 2009). A small portion of the participants
reported being less confident with their providers after exposure to DTCA (Abel et al.,
2009).
The three research articles about DTCA showed varied approaches to assessing
the impact of marketing on decision-making. The literature review indicated that patients
looked for any sign of hope and that patients would search for any opportunity to change
the odds (Reyna et al., 2015; Schildmann, Ritter, Salloch, Uhl, & Vollmann, 2013). This
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research incorporated a review of web based DTCA currently in use and accessible on the
web. I focused on developing an understanding of the types of messaging used in the
advertising of cancer related services and the potential framing effects on future cancer
patients. In addition, understanding the “perceived credibility” by consumers toward the
organizations using DTCA and the potential influence on decision-making was relevant
(Epstein & Gramling, 2013).
Fuzzy Trace Theory
In this section, I provide input from researchers in the field of psycho-oncology.
Researchers have suggested various theoretical approaches to describe the elements of
oncology specific decisions (Bodie et al., 2011). I reviewed dual process theories, such as
FTT, to explain the connection and divisions of multiple influences (i.e., logic and
emotion) in decision-making.
Reyna et al. (2015) referred to the “conflict” that occurred during dual process
decision-making and the influence of individual characteristics on ways in which the
conflict was addressed. Epstein and Gramling (2013) wrote about dual process decisionmaking and suggested patients lacking all disease information at the initial encounter
endured additional stress or confusion. The terms, used by Epstein and Gramling (2013),
differed from what Reyna et al. (2015) used; however, there were similarities in the
meanings. For instance, Epstein and Gramling (2013) condensed cancer decision-making
into three categories: “simple, complicated, and complex” (p. 95S), which included the
terms “intuition” and “deliberation” as primary decision-making elements (p. 98S).
Deliberation is similar to verbatim recall and intuition to gist recall. In addition, Epstein
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and Gramling (2013) suggested concurrent movement between intuition and deliberation
in decision-making.
According to FTT, verbatim and gist memory are formed together, with gist
memory consisting of a simplified residual recall after the verbatim process occurs
(Reyna et al., 2015; Wolfe et al., 2015). Another way to think of the differences between
verbatim and gist is specificity and generality, respectively. Reyna (2012) suggested the
development of gist memory recall increased as people aged and became more reliable or
accurate with experience.
Researchers have suggested interference occurred more often with verbatim
memory recall and was less reliable (Broniatowski & Reyna, 2013; Reyna et al., 2015).
People develop verbatim memory from factual information (Reyna, 2008; Reyna et al.,
2015). This information would be reflected in the understanding of testing, staging, and
statistics, as related to treatment efficacy, survival data, and risk models (Reyna et al.,
2015).
The category of gist memory consists of the fuzzy portions of memory (Reyna,
2008). Reyna (2008) reported that the essence of the experience was what was included
in gist memory recall. Over time, gist memories will progress into categorical memory
recall with decreasing specificity (Reyna, 2008). The practice of patients reaching out to
others for support during their journeys could impact gist memory (Epstein & Gramling,
2013). In addition, patients who have been caregivers to patients with cancer will have
gist memories of the experience (Epstein & Gramling, 2013). Fukukura et al. (2013) cited
prior research by Miller that included the concept of chunks. The concept of chunking
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information is like gist memory, as it refers to a categorizing of information into more
manageable pieces (Fukukura et al., 2013).
Psychological Distance
Economic theorists attempted to understand when consumers have the right
amount of information and when too much information was given, thereby influencing
decision-making (Fukukura et al., 2013). Psychological theorists have suggested
decision-making was improved when sufficient time could elapse between an event,
allowing for a decrease in “information overload” (Fukukura et al., 2013). By redirecting
attention, patients can make better decisions with psychological distance, giving people
the opportunity to take a step away from the situation (Fukukura et al., 2013). The study
findings indicated that large amounts of information hindered the ability to receive and
consider all elements, which could lead to confusion, decision delays, and dissatisfaction
(Fukukura et al., 2013).
Fukukura et al. (2013) also cautioned that in some instances, distance did not
prove beneficial, and participants could not recall specific detail. Following FTT, detailed
memory is more consistent with verbatim memory and is recognized by researchers
immersed in work with dual process theories (Reyna et al., 2015). Understanding the
amount of time that elapsed between the diagnosis and commencing treatment could be
beneficial.
Summary and Conclusions
Significant research findings substantiated the need for further study regarding the
relationship between dual cognition and decision-making for patients diagnosed with
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cancer. Multiple unique patient variables were presented in the literature that influenced
decision-making beyond what provider communication provided. Patient variables,
combined with provider variables, in addition to the complexity of a diagnosis of cancer,
would create opportunities for researchers in the development of communication tools.
The influence of external variables on decision-making by patients diagnosed
with cancer was well established in recent literature reviews, as cited in this document.
Researchers have recently recognized the influence of external variables on the decisionmaking process of patients. Therefore, this study would help build knowledge in the areas
of FTT, dual process decision-making, and DTCA, and these could influence the
decision-making process for individuals diagnosed with cancer.
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Chapter 3: Research Method
Introduction
I intended for this study to collect data that would help develop a deeper
understanding of the decision-making experience for patients newly diagnosed with
cancer. According to Jacobsen and Andrykowski (2015), it was only as recent as the
1980s that the stigma of a cancer diagnosis began to fade. From that same period,
according to Jacobsen and Andrykowski, psychology and health behavior theories started
to take strong shape, and the field of psycho-oncology started to form. The relationship
between emotion and cognition, in the scenario of a diagnosis of cancer specific to
verbatim and gist recall, had limited representation in the literature and merited further
study.
In Chapter 1, the study background, problem statement, study purpose, and
research questions were presented. Chapter 2 included the outline of the variables or
influencers identified in the literature as potentially influential to the decision-making
process. Chapter 2 also included greater detail of FTT, verbatim and gist memory, and
psychological distance. In Chapter 3, I outline this research design. The components
included in Chapter 3 also show support for the selected approach.
Research Design
I chose qualitative research and case study design as the methodological
framework for this research. Qualitative research focuses on developing answers to
defined research questions (Center for Research Quality, 2015; Maxwell, 2013; Patton,
2015). I selected case study design for the unique properties of this method. Researchers
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can use case study, according to Creswell (2013), to gather an in-depth understanding
about real-life cases studied. Case study is also useful for the development of themes
from detailed field work research (Creswell, 2013). This research included the multiple
case study approach with replicated interviews to assist in generalizing the findings.
According to the ACS (2016), over 173,000 Californians faced a new diagnosis of
cancer during 2016. The central phenomenon of this research was the decision-making
process for patients newly diagnosed with cancer. After an extensive literature review,
factors, suspected of influencing the decision-making process, were included in this
study.
I chose case study for the valuable development of themes from detailed field
work research. Researchers can use case study to gather in-depth understanding about
real-life cases being studied (Creswell, 2013). This research included the multiple case
study approach with replicated interviews to assist in generating themes and generalizing
findings.
I considered other qualitative research traditions, such as ethnography, grounded
theory, phenomenology, and narrative. I did not select ethnography due to the reliance on
greater levels of field work. I did not focus on culture, as seen in ethnography. Grounded
theory did not include enough specificity of data needed for this study, and I did not seek
to develop a new theory. In addition, I did not select phenomenology; however, it was
closely related to case study. The decision-making process studied was not focused on the
lived experiences, as would be consistent with phenomenology, rather the influence of
defined variables. The higher level of data specificity and participant exposure made case
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study a better method for this study. Finally, narrative research was not the ideal
approach to meet the broad data collection needs of this research and was not the story of
patients’ lives.
Role of the Researcher
Almost all participants were new introductions to me. I knew one participant
through an established relationship. I did not work with any participants. I decided to
avoid any suggestions of pressure or coercion and did not interview individuals I worked
with even if they met inclusion criteria.
I considered potential areas for bias during the development of this research.
Potential bias did not stop at study design, and I considered bias during each phase of the
study execution, analysis, and final publication. I offered a journal as the only item
available to participants.
Methodology
Sampling and Sample Size
I used purposeful sampling and snowball or chain sampling for this research.
Purposeful sampling provided the most effective method for identifying information-rich
participants from the study population (Maxwell, 2013; Patton, 2015). This sampling
approach included research participants in the process of recruitment (Sansour, Tong,
Jaber, Talbi, & Julliard, 2010).
I evaluated each individual interested in participating using the study criteria.
Participants enrolled were between the ages of 25 to 80, without cognitive impairment,
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with a first diagnosis of cancer, and lived in California at the time of diagnosis. I did not
include the stage of disease or primary site in the participant inclusion criteria.
The sample size in qualitative research is not based on statistical or mathematic
formulas (Dworkin, 2012; Miles, Huberman, & Saldana, 2014; Patton, 2015).
Consideration of the study sample size was important during the selection process, as
well as during analysis. According to Miles et al. (2013), the number of cases sampled
can impact the analysis portion if the number is too large number or if the interviews are
complex and lengthy. Attempting to complete qualitative analysis with excessive
amounts of participants or data can lead to difficulty keeping data structured and may
extend study completion. In consultation with the committee, we agreed on a research
sample size of 10 participants.
Saturation, as it relates to sampling, is a hallmark point that characterizes
comprehensive qualitative research. Saturation in data collection occurs when the process
of collecting and analyzing additional data does not produce concepts that are new
(Rothman et al., 2009). Another way to explain saturation is a point in the research where
concepts are repeating, and new content is not added. Saturation is also discussed in the
section on data trustworthiness.
Participant Selection
I employed multiple strategies for study participant recruitment. The categories
for recruitment strategy included (a) community engagement, (b) social media, and (c)
daily personal interactions. I provide details for each approach in the following
paragraphs.
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Community engagement opportunities provided several venues to advertise and
recruit participants. Patient support groups were one example of an opportunity for
researcher interaction with individuals diagnosed with cancer. There were many support
group members who did not meet participant inclusion criteria. Those who did not meet
the inclusion criteria forwarded information to support group members who might be
eligible, according to the snowball or chain sampling strategy. I used the ACS website to
obtain a list of support group resources for locations throughout California
(https://www.acs.org/). I completed web searches focused on supports groups in both
inpatient and outpatient cancer centers.
A Google search of the term churches supporting cancer patients in California
resulted in over 83 million hits, with many duplicates. To reduce the total number of web
results, the strategy I used included (a) removing duplicates, (b) removing websites in
languages other than English, and (c) identifying church systems or affiliations. I
contacted churches from all denominations and requested to post and distribute research
flyers (Appendix A) within their congregations.
Social media also provided an opportunity to reach individuals throughout the
state. I reviewed organizational social media guidelines from oncology related sites.
Some professional organizations developed guidelines for social media use. For instance,
the Journal of Clinical Oncology published rules for social media use (as cited in Brophy
Marcus, 2014). I also used Facebook, Twitter, and LinkedIn for the social media
advertisement strategy. Brophy Marcus (2014) noted the three social media tools as
useful in other research advertising. I included a study-specific Facebook page that
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included the recruitment and supplemental paperwork approved by the IRB. I monitored
the Facebook page regularly, which I set to the maximum level of confidentiality. The
use of social media in study advertisement and recruitment has expanded, and researchers
have proven it as an efficient and cost-effective strategy (Valdez et al., 2014). The
materials, posted on the social media websites, included the same advertising materials
approved by the Internal Review Board (IRB); one may find these in the appendices.
I screened individuals who expressed an interest in becoming a study participant
for meeting enrollment criteria, and then scheduled them for an interview. I obtained
consent before proceeding with the audio recorded interview. I did not conduct
interviews on the same day as initial contact.
I merged the social media venue with the academic environment through
university-based posting. I posted research advertisements on the California State
University Bakersfield LinkedIn site. I also used the Walden online research participation
system as the second academic advertisement strategy.
Examples of daily interactions included personal introductions made in nonwork
environments. During the recruitment phase of this study, I traveled a significant amount
and held a position of project director and consultant. I carried copies of the IRB
approved flyer and distributed these to individuals, as appropriate, who I met in organic
settings.
Research Questions
Research Question 1: What are the information based (verbatim) factors
influencing cancer treatment decision-making for patients diagnosed with cancer?
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Research Question 2: What are the emotional based (gist) factors influencing
cancer treatment decision-making for patients diagnosed with cancer?
Research Question 3: Are there factors outside of verbatim or gist examples that
are reported as influential in the cancer treatment decision-making process in the study
population?
Data Collection Instrumentation
Consent
I obtained signed consents after the participant reviewed the research flyer, which
was prescreened with the IRB approved screening tool. The consent template included
the study background, procedures, volunteer rights, risks and benefits, and other crucial
elements. Before participants signed the consent, the participant received the opportunity
to ask any additional questions. The consent included the agreement to allow for audio
recording of the interview session.
Interview Protocol
I developed an interview protocol for this study. The document included specifics
about the interview process, and I used the document to facilitate the interview process
and meet the IRB requirements. The protocol included a scripted opening, interview
questions, and follow-up notes. The interview protocol for this research is provided in
Appendix B.
Expert Panel Review
I assembled an expert panel to conduct a review of the interview protocol. Expert
panels are widely accepted for use in assembling experts in the field to provide
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knowledge on a given subject (Renn, 2015). In this study, assembling members in various
capacities of healthcare provided an opportunity for in-depth and constructive feedback.
The focus of the expert panel review was to test researcher-developed questions and the
approach to interviewing. The panel members for this study occurred in different
geographic areas of the United States. To accommodate the geographic separation of the
panel members, each panel member received the study parameters, and I then contacted
them by phone for discussion. I collected and considered all discussion points from the
panel review.
Five individuals from various healthcare and oncology roles served on the expert
panel. The panel members consisted of two men and three women. The professional roles
of the panel members, at the time of the study review, included (a) executive in
healthcare administration, (b) oncology surgeon, (c) research nurse, and (d) oncology
program directors. The panel members were selected for their experience in current and
past roles. The healthcare executive panel member also had IRB experience. All panel
members had broad experience with research and patient relationships. One of the
oncology service line directors also had substantial experience in behavioral health and
outreach programs. The second oncology service line director had clinical nursing
experience and experience with patient assistance programs. Finally, the research nurse
panel member had a long history in writing and conducting research related to life
threating diagnoses.
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Procedures for Participation and Data Collection
In this section, I provide the procedures for participation and data collection
detail. Data were collected through in-person in-depth interviews. I collected all data as
the primary researcher. Data collection occurred in three segments, described in the next
paragraph.
The first step of data collection included the audio-recorded interview. I used the
research protocol during the interview to stay track with the interview questions. I
conducted audio recordings of all participant interviews, and all audio recordings met the
same levels of confidentiality as other forms of data. I also made notes during the
interviews to ask clarifying questions. The notes were shredded immediately following
the interview because the responses were within the audio recording.
Next, I offered each participant a journal at the end of the interview. A sticker was
placed in the inside of the journal for participant reference. The language on the sticker
read, “Please journal any and all experiences related to your treatment decision-making.
There are no directions or rules given for journaling. Include anything you wish to share.”
Four participants accepted the journals, but no participants recorded notes in the journals.
Third, I attempted a follow-up telephone call 45 to 60 days after the in-person
interview. The purpose of the telephone call was threefold. First, I used the telephone call
to confirm any outstanding questions that came up during the transcription process of the
initial interview. Second, I used it to request participant feedback of any additional
decision-making experiences that had not been covered during the interview. Third, I
used it to let the participant know that they were exiting the study.
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I completed a web based review of cancer center advertisement occurring in
California. I included website advertisements for cancer services within California in my
review. I removed the previously planned public or community based newspapers,
magazines, or other publications. I evaluated the information gathered in combination
with literature specific to influence from advertising.
Data Management and Analysis Plan
I was the primary tool for data management and analysis. I conducted the initial
thematic analysis using hand coding. In addition, I prepared in-person interviews, journal
notes, and follow-up call notes in transcription form. I only used software tools to aid in
creating word mapping and clusters for analysis and identification of themes in the data.
A naming structure was created using hand coding and excel tables. I developed themes
and re-evaluated these as the naming structure emerged. Computer-assisted quality data
analysis software (CAQDAS) was considered but not used.
Methods to Ensure Data Trustworthiness
I completed ensuring data trustworthiness through several methods. In this
section, I provide credibility, transferability, dependability, confirmability, and ethical
procedures. Each category of data trustworthiness added value to this research, including
the combination of methods that provided trustworthy data.
Credibility
Strategies for establishing credibility included triangulation, member checking,
prolonged contact, and saturation. The potential influence to credibility of participant
responses, as based on the types of interactions, locations, and other fieldwork specifics,
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were recognized, as based on researchers’ suggestions (Creswell, 2013; Patton, 2015). I
held in-person interviews in neutral locations at the preference of the participant.
Patton (2015) referred to triangulation as a “test for consistency” (p. 20).
According to Maxwell (2013), researchers cannot assume triangulation ensures increased
validity. For example, if three methods are used to triangulate, but each of the methods
are at high risk for bias, triangulation may not be successful (Maxwell, 2013). One must
evaluate the credibility of each method needs prior to establishing a strategy for
triangulation. According to Patton (2015), triangulation can be applied to data,
investigator, theory, and methodology.
For this study, I focused on “data triangulation” (Patton, 2015, p. 20). The
triangulation methods included participant interviews, follow-up calls, and literature. I
developed the in-person interviews to elicit “episodic-memory” (Patton, 2015, p. 20).
Using episodic-memory indicated a better data opportunity for gathering rich participant
responses.
I modified the strategy of member checking from the earlier plan, as detailed in
Chapter 4. I prepared the audio recording of interviews in transcription form for data
analysis. I offered journals to participants. Modifications to the plan for journal notes are
also provided in Chapter 4.
This study included prolonged contact with participants. Three planned contact
points with the participants were used, interview, follow-up call, and data analysis. This
prolonged contact with the data allowed for greater opportunities to validate the data and
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ensure accuracy. Prolonged contact strengthens the trustworthiness of the data and
reduces self-report bias (Maxwell, 2013).
I defined saturation earlier in this document. The strategy for sampling,
advertising, and recruitment in this study was strong. I planned many methods for
identifying study participants and believed that meeting saturation would not represent a
problem. If recruitment occurred slowly, I planned to use additional connections and
social media postings in the approved IRB materials.
Transferability
According to Patton (2015), transferability refers to extending the findings to
other situations. Generalizability is another term used for transferability. In this study, I
met transferability by focusing on the relationship between emotion and cognition in
decision-making. Other factors existed that influenced decision-making for patients in the
study populations, but these were not the focus of this research.
Dependability
Dependability is important to ensure that other researchers can recreate and build
on a study using the path the initial researcher has prepared (Thomas & Magilvy, 2011).
Thomas and Magilvy (2011) referred to the development of an audit trails for
dependability. I prepared a study so other researchers could easily audit for the study’s
purpose, participant selection process, data collection, length of study, and detailed
analysis.
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Confirmability
Confirmability focuses on the entire study, with special attention on the findings
of the study. Thomas and Magilvy (2011) reminded researchers to consider if other
researchers would come to the same conclusion after reading their research. Examples of
confirmability included audit trails of the data analysis process. I created and saved
classification structures and all processes or materials used in my data analysis steps, as
suggested by researchers (Creswell, 2013; Thomas & Magilvy, 2011).
I also completed research by considering reflexivity. According to Patton (2015),
this term revolves around “self-awareness” (p. 20). Researchers must always be aware
that when left unchecked, they could allow personal biases to enter the work. Working
with the expert panel of advisors, I reflected on many of the steps taken during the
dissertation process. Reflexivity is easily applicable to every section about
trustworthiness, and when used properly, it exhibits a commitment to academic and
scholarly rigor.
For this study, I used the following: (a) database of all raw data, including
interview transcripts, journal notes, and follow-up call notes; (b) all notes developed
during the thematic analysis, including coding approach, word trees, tables, and other
items developed and used during data analysis; and (c) a comprehensive list of all
peripheral materials, cited or not, that was used during data analysis.
Ethical Procedures
I considered ethical procedures in all research paramount. The IRB approved and
granted the study approval, with the number of 11-28-16-0508681. All recruitment
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materials were also IRB approved. All methods of data collection, detailed in this
document, were approved by the IRB, and these were followed. Rigorous steps were
taken to follow all data confidentiality methods detailed in this chapter.
I did not conduct the study within my work environment to mitigate potential
ethical issues due to work place influence. There was also no sponsorship of the study,
removing potential bias in the findings. I held no position of power, and there were no
incentives offered to participants.
Summary
The details of all aspects of the research methods for this qualitative case study
were provided in this chapter. Support for the selected approach and details of the
sampling and recruitment strategies were defined. I also provided the steps taken for
adhering to the stringent goals for scientific rigor and dependability. I concluded the
chapter by providing the detailed plans to ensure data trustworthiness. In the next section,
I provide data findings and analysis.
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Chapter 4: Results
The objective for this study was to collect treatment decision-making stories
directly from patients who were recently diagnosed with cancer. The stories were coded,
themed, and interpreted to develop an understanding of decision-making using FTT. The
research questions were as follows:
Research Question 1: What are the information based (verbatim) factors
influencing cancer treatment decision-making for patients diagnosed with cancer?
Research Question 2: What are the emotional based (gist) factors influencing
cancer treatment decision-making for patients diagnosed with cancer?
Research Question 3: Are there factors outside of verbatim or gist examples that
are reported as influential in the cancer treatment decision-making process in the study
population?
I developed the research questions using literature review findings and FTT, with
a focus on verbatim and gist recall. Interview questions were developed in accordance
with the research questions above. I developed 16 interview questions and mapped these
to the associated research question (see Appendix B).
Expert Panel Review
I assembled an expert panel for study review. The emphasis of the expert panel
review included an evaluation of multiple study design components. The expert panel
provided insights and recommendations on the researcher-developed questions, approach
for interviewing, and process for data collection. The expert panel members resided in
different geographic areas of the United States. To facilitate the communication process
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with members, I prepared a PowerPoint document that included study components for
review by expert panel member. I emailed the document to each panel member and
obtained feedback from the panel members using phone calls, in-person reviews, and
emails. Panel members suggested changes to the interview question order and noted their
concerns with participant compliance with the earlier plan for member checking and
journaling activities.
Based on the expert panel review, I modified the existing study parameters, as
detailed in the following paragraphs. I compiled all recommendations and reviewed these
with the committee chair before I made changes. I modified the order of interview
questions. Questions that seemed similar were spread out within the interview protocol
(Appendix B). The final version of the interview protocol reflected the weaving of
questions that facilitated the natural story telling process without inadvertently
influencing participant responses.
I accepted the recommendation by panel members to modify the member
checking process in two ways. First, I re-asked interview questions during the interview
if a lack of clarity existed with the response. This process resulted in the process of
asking clarifying questions or reading responses back to the participant to ensure
accuracy and credibility of the data. In addition, if a portion of the transcribed interview
was unclear, I planned to discuss the question with the participant during the follow-up
call.
The expert panel also suggested few, if any, participants would agree to
journaling. I decided to offer journals to each participant to be used if they wanted to
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journal. Four journals were distributed, and no journals were returned. This aspect
showed the panel suggestion was accurate.
The panel members also expressed concern that recruiting would be difficult if
attempted too close to the date of diagnoses. The panel recommended defining eligibility
from the date of diagnosis through the first course of treatment. Recruitment did prove
challenging when patients were newly diagnosed. Recruiting became easier a few weeks
out from the date of diagnosis.
The final adjustment to the study came from committee review. The original
study included this statement: “It is pertinent to the proposed research to include inquiry
into the amount of time between the diagnosis and commencing treatment.” I later
determined that this piece of information would be difficult to use. I removed any focus
on questions related to the number of days that transpired between diagnosis and the start
of treatment from the interview design.
Research Setting
I collected data using interviews that consisted of open-ended questions. I
developed subquestions for some of the interview questions to help facilitate the
interview process or provide clarification if participants did not understand the questions.
The primary setting for the completion of interviews included neutral locations selected
by participants. Three participants were in the process of receiving chemotherapy and
under physician direction to follow strict infection control measures. For this reason, I
accommodated the request for these participants to complete phone interviews. In
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addition, due to geography and transportation issues, I conducted a phone interview for a
fourth participant.
I completed follow-up telephone calls, as well. I asked participants if they had any
additional experiences they would like to share that were not covered during the
interview. The notes, obtained from follow-up calls, were added to the transcript data and
part of the analysis process. I released participants from the study at the end of the
follow-up call and reminded them of the confidentiality practices for this study.
For the secondary data analysis, I completed a review of California web-based
cancer advertisements. I restricted the review of cancer advertising to the advertisements
found during the web search. The findings from the cancer advertising are provided in
this chapter, under the cancer advertising and DTCA section.
Demographics
At the time of diagnosis, all participants lived in California. To ensure
confidentiality of participants, the geographic distribution presented was separated by
regions. According to the California Travel & Tourism Commission website, California
consists of 12 regions (http://www.visitcalifornia.com). At the time of the interview,
study participants lived in California’s North Coast, San Francisco Bay Area, and the
Central Valley.
All inclusion criteria were met. As previously stated, no criteria existed for the
type of cancer. The goal was to obtain participants who were diagnosed with different
types of cancer. Participants in this study included individuals diagnosed with cancers of
the breast, thyroid, prostate, head and neck, lymph nodes, and lung.
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Data Collection
I obtained IRB approval November 28, 2016. I completed this study as the
primary researcher, with no research assistants. Using a random number process, I
separated the 481 cities within California into numeric segments of 25 cities each. I
completed recruitment efforts per segment until I reached the required recruitment.
The recruitment efforts I followed included searching each city using matching
steps. First, the ACS page for support groups was searched by city name. I attempted to
contact each support group listed in the ACS city search. Contact with support group
leaders was attempted through telephone calls, emails, or U.S. postal mail service. Next, I
searched cities on the web for cancer support services within that area. I identified webbased support groups by typing “cancer support,” followed by the city being searched. I
then attempted to contact any support resources not already identified using the ACS
website. I included nearly 100 California cities in recruitment efforts, at the time
recruitment was closed.
I enrolled, interviewed, and discharged a total of 10 participants for this case
study and found recruitment difficult. Many individuals expressed an initial interest in
participating and later declined. Recruitment of participants included individuals with a
first diagnosis of cancer. I attempted to recruit and interview participants as close to the
date of diagnosis as possible. Staying as close to the original date of diagnosis was
preferable to avoid confirmation bias. However, patients, early in their journey and in the
throes of adjusting to a diagnosis of cancer, were difficult to recruit.
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I created data collection instruments approved by the IRB. The approved data
collection instruments included two versions of the invitation to participate, an informed
consent, screening questions, and an interview protocol. The invitation to participate and
consent were provided for each contact made during the recruitment process. I did not
send out the screening questions, but I used these to screen for eligibility when contacting
a potential participant. I used the interview protocol during the interview process. A study
protocol was developed form the IRB application at the requests of oncology practices
considering placement of invitation flyers in common areas approximately 2 months after
recruitment was opened. The IRB confirmed that approval was not necessary for this
information to be shared.
The three categories of recruitment included (a) community engagement, (b)
social media, and (c) daily personal interactions. The recruitment activities used for each
category are detailed in the following section. Deviations to the original recruitment plan
are also provided in this chapter.
The recruitment efforts within the category of community engagement included
(a) in-person support groups, (b) web based support groups, and (c) church groups. It was
immediately apparent from the first segment of cities that using church groups to recruit
would yield limited, if any, participants. Church group recruitment was also extremely
labor intensive. The use of church groups was stopped after the first segment of 25 cities.
The ACS website represented the primary source I used to identify locations for
in-person support groups. I reviewed the list of support groups on the ACS web and
found that the ACS most often supported these support groups. There were also instances
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where the support groups listed on the ACS site were sponsored by the facility where the
support group was held. I contacted support group sponsors listed on the page. Many
contacts with support group sponsors produced an agreement to distribute invitations to
participants during support group meetings or through other support group contacts.
Many examples of support groups existed that were led by the facility or
organization and not the ACS. In those instances, the responses I received usually
included the need to have the facility’s IRB review the invitation to participate before
distribution could occur. I often had to place several emails or calls to confirm facility
IRB approval to distribute flyers during support group meetings. For example, IRBapproved study documents were submitted to the ACS, Cancer Survivors Network (CSN)
on January 5, 2017. The CSN website provided another opportunity for recruitment
through the ACS resources (https://csn.cancer.org/). I received approval to post on the
ACS-CSN website, and I posted the invitation to participate on January 12, 2017.
As noted above, I only included local churches in the first random order segment
of California cities. My initial attempt of using Google to search churches supporting
cancer patients in California returned over 83 million results. I then used the website,
http://www.ChurchFinder.com, to locate churches within each city. In most cities, I
located more than 20 English speaking churches. In some larger cities, I identified 100 or
more English speaking churches. For each church, I requested to speak with the
individual in charge of support groups. It was a nearly unanimous response from church
staff that the church secretary would review and post the flyer on the church bulletin
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board. Only one church approved my request to post the invitation flyer in the church
newsletter. No participants were located through church recruitment efforts.
For social media recruitment, I used Facebook, Twitter, and LinkedIn. I also used
personal support group webpages linked to Facebook pages. As noted above, I searched
web-based support groups by city, and located many social media links. This recruitment
strategy also required multiple reposting’s of the study advertisement, on numerous social
media platforms, each week. The materials, posted on the social media sites, included the
invitation to participate, informed consent, and study protocol. I developed a studyspecific Facebook page, which I shared through Twitter and LinkedIn. I sent several
Tweets that advertised the study. The process of tweeting did not produce substantial
interest in the study.
I requested to add the study opportunity to the Walden online research
participation system. Walden accepted the request. There were no participants identified
from the Walden online system. My original plan included posting on the California State
University Bakersfield (CSUB) academic site. After further review, I decided the post on
the CSUB website would not be useful due to the primary age group in attendance.
Daily personal interaction included spontaneous introductions to individuals in
nonwork environments. Travel, volunteer outings, and introductions through family or
friends represented examples of nonwork related personal interactions. The personal
interaction settings provided opportunities to hand out invitations to participants. If
individuals were not eligible for the study, they were asked if they would be willing to
share the information with anyone they knew as eligible. In addition to the recruitment
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efforts above, four community-based oncology offices agreed to provide flyers. The
practices provided the invitation to participate flyers in common patient areas.
Participants were identified and enrolled through this partnership.
Individuals expressing interest in participation in any avenue were screened for
eligibility. The questions on the IRB screening question tool were asked of each potential
participant. When I identified a potential participant as eligible, I scheduled him or her
for an interview. Moreover, each participant consented to an interview that included an
audio recording. I used two audio recording devices in the event one recording device
failed. I did not take field notes, only notes made during the interview as a reminder to
ask a clarifying question. I attempted to contact each participant for a follow-up. I called
participants 45 to 60 days after the initial interview. In some instances, I made contact
later than 60 days. When participants provided additional interview feedback during the
follow-up call, I added the new feedback to the interview transcription.
Several weeks passed with no participants coming forward, and revisions to the
flyer were requested through IRB. Feedback from several of the support groups and
social media sites provided suggestions for a more appealing flyer. The IRB approved the
changes to the advertisement flyer language, and the new flyer language was used
(Appendix C). I reevaluated the recruitment strategy several times during regularly
scheduled calls with the committee chair. Changes to the recruitment strategy were
detailed above, but the changes were not sizeable changes. Incorporating a research
assistant for the completion of the social media postings might have aided in recruitment.
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Support group contacts referred five participants. Some of the support group
attendees, who did not meet the inclusion criteria, forwarded information to support
group members who might be eligible. This word-of-mouth was detailed in Chapter 3 and
was key for the snowball or chain sampling strategy. Four participants became aware of
the study through flyers located in oncologist offices. One participant became aware of
the study through personal interactions.
Enrollment started in late November 2016. The first participant was enrolled in
January 2017, with the final participant enrolled in June 2017. As I mentioned in a
previous section, I found recruitment difficult. After multiple discussions with the
committee chair and adequate data collection consensus was reached, and the decision
was made to close recruitment with 10 participants. I transcribed and analyzed the
participant interviews. Saturation was achieved through the multiple steps of data
analysis detailed above. When no new codes, categories, or themes emerged, the
committee decided that I reached data saturation.
I could not locate a comprehensive list of all cancer treatment service locations in
California. Options to create a list of California cancer centers with data, purchased from
the California Department of Health, were cost prohibitive for this study. Thus, I changed
the original plan to collect cancer center materials in the form of pamphlets and public or
community-based newspapers or magazines. I decided to conduct a web search using
Google. The term Cancer Treatment in California was used for the search. I reviewed the
first 10 results and ads produced by this search and created 159 links. From the 159 links,
I identified 53 California cancer service locations. I did not include cancer services
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outside of California in this review for advertising language; however, I personally
viewed the TV advertisements while in California. Minimal research existed on the
language used during the advertisement of cancer services, but research did exist, which
would be useful to understanding that language. However, this aspect was not the focus
of this research study. I completed a search of advertising language for each California
cancer treatment location. In addition, I kept notes of personally viewed television
advertisements about cancer that I viewed while in a California location. The web-based
cancer advertising findings are presented in the data analysis section.
Data Analysis
I conducted the analysis of participant responses using hand coding, categories,
and theming activities. I first coded participant responses to interview questions in three
phases. Interview Questions 1, 3, 4, 7, 9, 10, 11, 12, 14, 15, and 16 made up Phase I. I
coded and themed Interview Questions 2, 5, 6, and 8 in Phase II. Phase III included
Interview Question 13, and I evaluated and coded the web-based cancer center’s
advertising as a final phase.
I began interviews by asking participants to recount the day they received their
diagnosis. Most participants began responses with a recollection of precise dates and
locations where they were when they received their diagnoses. Many of the participants
stated they recalled exact locations, times, or even the weekday. Examples of precision in
recall included P1 stating, “I remember exactly, the phone was on my desk and it was
exactly 3:35.” P5 added, “It was late afternoon.” Six participants received their results
over the phone. Of the six participants who received phone confirmations, four
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participants were called by their physicians. None of the participants expressed
displeasure with the ways in which they received their results. Multiple participants
expressed that they did not like waiting as long as they did for results.
All codes, developed from the hand coding exercises, were evaluated, and the
overarching themed categories were established. The primary categories included (a)
family/social dynamics, (b) psychological/emotional distress, and (c) decision-making.
Cancer advertising follows the data analysis section and provides the secondary data
review detailed in the study plan. The following sections and paragraphs will provide the
research findings and supporting data. The final step of analysis includes evaluating the
themed categories and understanding the influence of the categories on the original
research questions.
Family/Social Dynamics
Every participant described a variation of family/social dynamics. Field
observations occurred during interviews, and participant terminology were used to
understand the influence of support or additional stress from experiences within the
family/social dynamics. Participants spoke of positive situations that were the foundation
that helped them get through their journeys. Participants also described situations that
caused additional stress, pressure, or unease that included the loss of privacy, family
tensions, and unsolicited input. Some patients detailed mixed situations with the
existence of both positive and negative family/social dynamics.
Supportive. Supportive examples included unwavering family and social support.
P4 stated, “My daughter and my grandson are like my guardian angels. There have been
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no secrets… I have such a wonderful support system. I have my faith, my church family,
a wonderful job.” P9 added, “She’s been there every step of the way with me. Every
doctor’s appointment… I would have been totally lost if it hadn’t been for my wife.”
Participants also described support as coming from their places of employment
and friends. P8 stated, “[They] have all stuck it out and they seem to do whatever they
can to help us out.” P2 added, “She came in, got the brush, put my hair in a bun, and ran
out with the car double parked.” In addition, P1 stated, “One of our friends barbequed
and only invited a couple of our friends so that I could get out of the house… she also
had the sanitizer at her door.”
Positive family/social dynamics also came in the form of support groups. P3
stated, “Having guys that I could talk to… We became pretty good friends. It was nice to
have somebody to talk to.” P10 added, “[They were] very supportive and so
understanding and they really took me under their wing.”
Additional stress, pressure, or unease. The second category of family/social
dynamics included codes consistent with additional stress. The theme of additional stress
included categories of loss of privacy, family tensions, and unsolicited input. This
category evolved, as participants detailed the behaviors of others.
Descriptions of disregard for personal boundaries included the loss of privacy or
modesty. P5 said, “Everyone gets to see you” P1 added,
I told them I did not want them to cry. I did not want them to break down. They
needed to go in there and listen… Also, I needed them to be the ears for me. In
case I couldn’t pay attention… she said I was being ridiculous.
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P2 stated, “This is how I needed to deal with this. I did not want [family member]
involved.” Participants insisted that support was very helpful, but privacy, modesty, and a
sense of individual control should be preserved.
Participants described situations of family tension prior to the diagnosis. P1 said,
“[They] came around more out of guilt.” P6 stated, “There has been a little bit of tension
between the family. Although my doctor did request that I reach out to those family
members… I chose not to.” P2 stated, “[Name] usually made it about them.” P3 also
stated, “There is a hatred between her and I that goes real deep… I just did not want the
kids to have to live through that drama.”
Unsolicited input from the family/social circle were described by participants. P2
stated, “He called me and told me I do not have cancer…you are not going to have
chemo, chemo will kill you… I was so pissed off. Don’t tell me what I am going to do.”
P10 described the dramatic response from a sibling: “Oh my gosh, you might die.”
Participants also described alternative treatment methods as examples of unsolicited
pressure. P3 stated, “[Name] was really trying to push [the] product… and saying well
you gotta take more.” In some instances, participants described telling individuals to stop.
P1 said, “I don’t need you to question everything… I have to believe that the decisions
I’m making are right.”
Psychological/Emotional Distress
Some of the examples included in the previous section of added stress could
transition in this category of psychological/emotional distress. If or when that transition
occurs would be different for everyone. This category of psychological/emotional distress
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developed during the coding process when statements from participants described
experiences with greater emphasis than the earlier category of family/social dynamics.
This section includes the categories of (a) shock, confusion, or fear; (b) emotional
distress/fatigue; and (c) other feelings of guilt and participant identified psychological
needs.
Shock, confusion, or fear. Participants described shock, confusion, or fear
(current or long-term). P1 said, “I just remember breaking down.” P8 added, “I am pretty
much still in denial for the whole thing.” In addition, P10 included, “It is just so much to
take in. It is really best absorbed in pieces.” Moreover, P3 stated, “It struck me pretty
hard.” Some participants detailed a sense of confusion or, as stated by P2, an “inability to
focus or complete even the simplest task without instruction.” P5 said, “It isn’t chemo
brain, it is cancer brain.” P10 included, “It’s very hard to be the cancer patient and be the
advocate because you are so sick and your overwhelmed.” In addition, P6 said, “It has
been an ongoing mourning process.”
Fear was described in examples of short or long term. Fear statements included
immediate reaction, survival, and long-term impact of this journey. P10 said, “Cancer is
no longer a death sentence. But, it was very scary.” P7 included, “In my mind, it’s like
we gotta do something starting tomorrow.” P1 included, “[I had to] live for the babies.”
P2 also included, “That was my fear, that my kids were going to have to be without me.”
P7 stated, “Just to know that you need to be here for your family is what makes you want
to fight.” In addition, P10 stated, “It was a really big deal to go through it. Because to
have little kids [made it hard].”
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Participants described examples of long-term fear. P5 said the following:
I was really afraid of the chaos and the stress it was going to cause, cuz it does…
Even after you are done with treatment it’s there. It’s like it will be there forever. I
am not afraid of it killing me, I am afraid of the stress.
P1 stated, “The doctor is not going to see me every day … who is going to watch
me, to make sure that it doesn’t come back? … I wanted to be monitored still more
closely. Also, they don’t do that.” In addition, P3 included, “I was more fearful for my
kids, their thoughts. What I could do to keep things on a normal basis around the house.”
Emotional distress/fatigue. The category of emotional distress/fatigue included
descriptions more profound compared to the previous section of shock, confusion, or
fear. This section developed from participant responses about the emotional toll of telling
others, especially children, about their diagnoses. In addition, the psychological and
emotional toll of treatment side effects, such as intractable pain, were present. Finally,
other feelings of guilt and participant-identified psychological needs were described.
Telling others about the diagnosis of cancer was described as causing additional
pressure or emotional fatigue in some participants. P4 stated, “When I told [name][they]
immediately broke down…. [they] got very emotional. I was consoling [them].” P3 said,
“When I broke the news to them my daughter took it pretty hard my son was okay,
what’s the next step?” P5 included, “My [relative] was the hardest one to tell. Because
my dad died from colon cancer. I was upset to tell him … I was bawling then and I said I
need to tell [relative].” In addition, P2 said, “That is hard because when you have to tell
people repeatedly when you see them it gets draining.”
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Participants described even greater emotional distress when they had to tell
children. P2 said, “In my head, I had this fabulous plan; it was this after school special.”
P4 included,
There is going to come a point when we need to talk to the children, when we
need to share with the children. But, I said we need to pray about this before we
do it because. I don’t want to scare them.
P5 stated, “I waited a few days to tell them. But, I told them, and I was really
strong and only had a little tear. But they didn’t have a lot of questions.” Participants also
acknowledged not being completely truthful with children about the extent of disease. P2
said, “I was worried… the older one was really freaked out. [Child] still doesn’t know
that it was the same cancer.”
Some participants described side effects as considerably more intense compared
to expectations. The experiences of extreme pain and expressions of psychological
distress were important to define. P10 said, “For 3 straight days, I was… practically
wanting to die.” P1 stated, “What if the next one kills me? … my body hurts so bad.
Also, it’s gonna get worse next time. So, I don’t want to do it. I’ll take my chances.” P7
included,
They tell you about losing your hair and stuff like that but they really don’t tell
you about the psychological part of going through. At one point, I wanted to quit.
They don’t tell you the psychological part of what chemotherapy does to you.
Other feelings of guilt and participant identified psychological need. Feelings
of guilt or other strong emotions were described by some participants. P2 said, “I feel
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horrible about being alive sometimes because it is not fair. Why is she dead and I am
alive?” Some emotions were associated with participation in support groups. P4 stated, “I
feel kind of bad… I have not had that journey to go through. I have not had those extreme
side effects and the sickness and the lack of support.” P5 also stated, “It is overwhelming
because every day someone new is diagnosed and comes on board.”
Participants described identifying the building-up of stress and need for
psychological support. P3 said, “I feel, you need some kind of psychiatric evaluation…
All the sudden, the reality of everything falls on top of me and I start crying.” P2 stated,
“Because of the stress, I cannot work. I would burst in to tears at work. I couldn’t focus. I
could not do my day-to-day job.” P7 included, “I don’t think I was ever scared. It was
just time for me to get off this roller coaster because it is just the emotions that get you
more so than the treatment.” One participant described benefiting from the experience
with cancer in others to help them understand the psychological impacts of cancer. P4
detailed the following:
I learned a lot because of a wonderful social worker at the cancer center. While
[family] was in chemo, I was in therapy with the social worker. I learned a lot
about cancer. The things I learned from the social worker and the things I learned
about myself. One of the things that have always stuck with me is when the
therapist told me is [the patient] had the tumor, but the entire family has the
cancer. In addition, it is so true. It affects every member, everyone that is close to
me this is affected. I learned a lot about that process. So, I was kind of ready for
it. Like, I just got to take an easy path.

65
Decision-Making
This section details the final theme developed from the interview data analysis:
decision-making. Participants described factors that influenced decision-making that did
not fit into the categories of family/social dynamics or psychological/emotional distress,
but these were significant for their journeys. Categories within this theme included (a)
influenced by experience of cancer in others, (b) avoidance, and (c) selection of treatment
location.
The decision-making roles, described by participants, varied and included
examples of both SDM and patient directed care. Eight participants described being
presented with treatment options and being allowed to select their treatment course. P2
described,
We discussed a lot that day. I think my appointment was 2 and a half hours long.
Then another hour with the [navigator]. [The doctor] did go over the options. [The
doctor] said basically you have three options that you need to think about.
In some instances, participants expressed feelings that included a lack of agreement from
the oncology team, but these remained consistent with SDM. P2 stated,
I made the decision that night. Also, I haven’t changed it… I could tell that [the
medical team] didn’t agree. They [asked], “Are you sure you want [surgery]?” I
said, “Yep, sorry.” But, they never made me feel like I was making a wrong
decision.
P4 said, “[The provider] didn’t seem happy about doing that. He thought it was kind of
severe. But, I said, ‘No, that is what I want.’”
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One participant described switching providers based on the lack of agreement
with the treatment plan. P10 said,
I felt like [provider] was overdoing it. I had done my own research and saw how
awful radiation is, it just does terrible things to you… and I didn’t want it, and I
didn’t feel like it was required. The only decision I felt I made, and I still consider
it probably one of the most important, was rejecting the radiation. That was a
cognizant decision I made… I found a doctor that I felt I could work with better…
it was oh so much a more agreeable plan to me. It didn’t feel as over the top.
One participant described leaving their community to seek medical advice and
treatment. P6 said,
I learned that it’s important that you don’t just take your doctors word for it that
you research, and you go in there prepared and asking your doctors questions. If
your doctors see that you are ill informed then they can easily just point you in the
wrong direction. But, if they see that you are on top of it and that you are as
knowledgeable as possible in the area given the resources that you have, I feel
like they do a better job.
Influenced by experience from cancer in others. In some instances, participants
described ways in which the cancer journey in others influenced their personal treatment
decisions. The amount of influence varied between participants. P2 said, “I am going to
fester with cancer and it is going to spread to the rest of my body. I know that has
something to do with [relative].” P5 added, “My father went through the colon cancer… I
was really afraid of the chaos and the stress it was going to cause.” P2 also added, “One
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participant detailed seeking more aggressive surgery due to witnessing poor outcomes in
family… [they] withered away. It was a horrible thing to witness. I wanted to do the
exact opposite.”
Other participants wanted to forgo a modality of treatment due to the side effects
they witnessed. P10 stated, “One man had been receiving radiation to his head. The
radiation is what finished him off.” P3 added,
My wife went through some heavy chemotherapy… it was supposed to give her a
better quality of life… which neither one of us could see. If it came back [for me],
the options for surgery were off the table. Also, then I would have had to do some
heavy chemotherapy.
In two participants, the experience with cancer occurred after the participants’
diagnosis and during their treatment. P1 said, “Well, a couple of months in to [my
treatment], [name] cancer came back. Everywhere… I freaked. I cried like for days
straight.” P6 stated,
I did later learn, now going through my experience, [family] had a very similar
diagnosis… but [they] didn’t do any follow-up treatment. [They] took [their]
doctor’s word for it. Also, as a result, about a year after, [they] had cancer and
was supposedly in remission it came back… that, for me, played a huge role on
my decision on what I should do and shouldn’t do.
Avoidance. Examples of avoidance were described: “I didn’t want to know
anything about anyone else that died” (P2). P4 stated the following:
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To be honest… I really felt led to just close it. I don’t need to go there… I don’t
need that to be what fills my mind on a daily basis. I had faith in my doctors, and
I have faith in my god. That is what I choose to fill my life with, is that faith. So,
it is not about being ignorant. It is just that I don’t want all that negativity. I don’t
want all of that in my mind.
P9 stated the following:
One of the biggest coping mechanisms was the layoffs at my work. I think that
situation helped me through this. I am glad that I kind of remained as oblivious to
it as possible that I just don’t think I would get it done if I (unfinished)… I
couldn’t do it again; let’s put it that way.
Decision-making roles, described by participants, varied from research to full
decision-making. Some participants decided to transfer decision-making roles to others.
Participants described being exhausted or confused and wanting to avoid negative
information. P4 stated, “She writes everything down, she does research, she asks
questions. I kind of listen to it … a couple of times my daughter says, no mom, that is not
what the doctor said.” P10 stated, “It’s very hard to be the cancer patient and be the
advocate because you are so sick and your overwhelmed.” In addition, P2 stated, “I
wanted [name] to extract the information that was helpful and give it to me.” P8
commented, “[Name] did a lot of research… doesn’t like to share stuff that is negative or
bad, so unless it is really important, we haven’t talked about it.” P9 included, “You know,
I never had to because my wife, oh gosh, my wife does a ton of research… so, she
basically broke it down for me… balancing optimism with reality.”
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Full transfer of decision-making was described in three participants. P8
commented,
[I] pretty much left it in his hands” (P8). “I am just the patient. I just have to do
what people tell me to do. It’s a pretty easy job. I just do what my wife tells me
and the doctors tell me. I go along.
P4 stated the following:
I put my care in the hands of my wife in the sense that she knew; she has been
quite the blessing to me; she was there to understand what I was going to go
through. It is not about being ignorant. It is just that I don’t want all that
negativity; I don’t want all of that in my mind.
Selection of treatment locations. The selection of treatment locations included
influence from external sources, as well as personal or family knowledge of treatment
locations. The main driver of external influence in the selection of treatment location was
insurance. Nine participants confirmed being referred to their treatment locations by their
insurance companies.
Feedback was provided by the nine participants referred to treatment locations by
insurance companies. Participants described examples of being satisfied, as well as being
frustrated with providers or insurance companies. Comments, regarding being satisfied,
included the following: (a) “People may talk bad about [insurance], but [they have] been
great to me” (P1); (b) “[We] heard nothing but good words about [physician]” (P8); (c)
“The [facility] up here is as good as you are going to get… the doctors here are highly
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regarded” (P3); (d) “[Provider] was a very nice… Very soft spoken. Very calming. Gifted
in what she does” (P4); and (e) “I had a really good experience there” (P5).
Statements of frustration were focused on wait times, delays in treatment, or
facility size and volumes. P2 stated, “I do have to say they [provider] kept delaying my
surgery. Also, a lot of back and forth.” P5 commented the following:
I had to go the whole weekend waiting… plus three days for the lab work. I
recommend not ever doing it on a Friday because it seem to extend. It was
horrible. Also, they didn’t call me… and I told her I was all upset not knowing.
P8 included, “In my opinion [facility name] has become such a cattle call.” In
addition, P9 commented, “My wife was very much afraid that I would be just caught up
in the system and be another number.” P1 stated, “I walked in there, and I said, ‘Oh my
God, this place is huge. So many people everywhere. So many rooms, so many
whatever.’”
Dual Process (FTT)
Overall, more gist responses were provided from participants than verbatim
responses. Cancer stage is the nomenclature used to define the extent of disease. The
cancer stage is coding schema built on specific information about the primary tumor site,
nodal status, and metastatic disease.
Some participants provided their cancer stage at various points in the interview
and with varying levels of recall:
The only other question I knew to ask was the stage because I knew stage is
something people ask about. I felt very blessed that I was told I was stage II. They
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found three lymph nodes and they removed them, they were clear. My
understanding is that is next to nothing. (P4)
P1 stated the following:
They explained to me after surgery I would either remain [same stage], if nothing
had changed. Or if they found it in the lymph nodes it [the stage] could go up…
LN were clean I still remained [the same] stage.
P8 commented, “Because it is… Stage IV. Ninety-five percent of everything is
not very positive on the internet.” In addition, P10 stated, “It came back thankfully only
Stage I.” P6 provided the cancer stage early with multiple verbatim details about the
testing and results that lead to the revelation of a higher stage from Stage I to Stage III.
P6 also left their community to seek a higher level of care.
Five participants did not mention cancer stage in their interview response until
they were specifically asked toward the end of the interview. They provided verbatim
details of cancer stage, specific tests, facility names, or other responses significant to
cancer staging: “It didn’t spread that much. It spread to two Lymph Nodes… one lymph
node completely was healed up, there was no more cancer in it” (P9). To retain
confidentiality of the remaining four participants, quoting their responses was
inappropriate (i.e., P3, P5, and P7). One participant included only a statement of the stage
and referred to the binder that holds the information about their diagnosis: “[They] gave
me this stupid cancer binder. I did not want the binder, it says I have cancer” (P2). This
participant also included, “In addition now I don’t even know, remember what I have”
(P2).
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Verbatim examples existed related to descriptions of treatment: “The surgery I
had was what they call a [procedure name]. They go in and take out your lymph nodes
along with the [organ]” (P3). P10 stated, “[I] went to the internet and looked up the
effects of radiation on the [body site], and I saw all sorts of awful possibilities that were
pretty good possibilities not just 5%.” P1 commented the following:
[Doctor] said basically you have 3 options. One is to not do nothing at all because
every person has the right to decline treatment. Everybody has a right to not want
to go through the chemo and the radiation and everything else… even though
[doctor] doesn’t recommend it. [Doctor] went over the next options… But,
[doctor] has said no matter which… I chose out of those options. The percentage
of my survival was exactly the same.
Participants included statements that indicated a lack of complete understanding
prior to starting treatment: “But, there were some things that were just left out in that
conversation. Or it was skimmed over” (P3). P10 commented, “I wish someone had given
me more thorough information.” Participants also described a lack of understanding
specific to the area of pain control and the options available to them:
No one told me that you need to take the pain meds before your treatment so that
they are already on board… This one particular drug just made me so miserable
with pain, and then I found out I could have taken something else. (P10)
P1 stated, “I never knew, they give you medicines, but the medicines have all kinds of
different effects. They treat all kinds of different things with one little chemical in there
or whatever.”
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The last interview question asked participants if they believed emotion or
information provided more influence during treatment decision-making. Four participants
easily said emotions. P1 stated, “Emotion. So, that I could still live.” P3 commented, “I
think it was more emotional. What I have been through with my wife and kids.” In
addition, P7 included, “But, it is the emotional, knowing that you have to keep going, the
knowing that this too shall pass this is almost over.” P8 stated, “Probably emotion. Also,
having my wife talking so highly of [doctor] for so long.”
Three participants stated both emotion and information influenced treatment
decision-making: “I think it was emotionally driven but I did have some real statistics”
(P2). P5 commented, “Emotions for the doctor I chose… But otherwise, the medical
facts.” Moreover, P10 observed, “I went with medical data and studies and proof… when
I made my decision [not to have] radiation, it was somewhat emotionally driven. You
don’t have to decide everything the first day.”
One participant exchanged the term faith for emotion and stated both faith and
information played a role:
My faith I would have to say comes first. But, I cannot leave out the medical
information that I have gained also because, to me, God has given me both. He
has given me my faith, and He has given me the blessing of having doctors, and
nurses and medicine that is used to be able to fight it. So, I wouldn’t be able to
choose one over the other. It’s a mesh.
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The remaining two participants stated information drove their decision-making:
“Knowledge. I feel that sometimes if we let our emotions take over we don’t always
make the best decision” (P6), while P9 stated, “The factual parts by a long shot.”
Cancer Advertising and DTCA
The first portion of cancer advertising includes participant interview responses
followed by the secondary data review. I asked participants what they could remember
about cancer advertising prior to their diagnoses. Recall of cancer advertising was not
significant for the period prior to their diagnosis: “Before I had cancer, I didn’t pay
attention” (P1). P5 stated, “Not before,” while P1 continued, “After the diagnosis of
cancer, participant responses included high levels of exposure to advertising.” P5
observed, “Now, it is like every other commercial on TV has something to do with cancer
awareness.” P5 commented, “Now, I see it all the time. It’s like was this around before,
and I never noticed it or what’s happening?”
Not all responses to cancer center advertising generated positive memories. For
example, P1 remembered, “A cancer lawyer suing because the hair didn’t come back
because of the chemo.” P2 stated, “It’s always the bald people.” P3 commented, “There is
a lot of that stuff going around… it kind of irks me.” P4 mentioned, “Class action
lawsuits, it’s cancer, cancer, cancer!” In addition, P7 stated the following:
You know the thing that gets me about the TV… some of the things to prevent or
help with a cancer… when you listen to the side affects you are like I don’t want
that. I understand they have to give information but sometimes all that
information can wait until the person asks about it.
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P9 commented, “They always seem very positive, you know, that almost every
cancer can be cured. But, unfortunately, I just don’t think that may be the case.” P10
remembered the following:
What I recall the most are… the pills, the detox, the organic juicing. It’s all over
the internet. It’s on the TV. Also, I had a number of questions because of course
they give their convincing arguments, so I remember that more than I remember
what you might call legitimate pharmaceuticals.
DTCA. The secondary data review focused on messaging in cancer advertising.
Previous researchers have included advertising methods and exposure of patients to
marketing in their literature (Abel et al., 2009; Tan, 2015; Vater et al., 2014). I
concentrated on web-based advertising messaging to complete this secondary data
review. I reviewed the verbiage of 53 California cancer treatment locations. The facilities
included in the secondary review are provided in Appendix D. I located and reviewed
mission statements for 25 facilities, and advertising tag lines for 18 facilities. No
advertising was identified for 10 of the 53 facilities.
Mission statements focused on phrases that promoted partnerships,
communication, treatment options, care statements, and the physical environment of the
facility. The messaging categories that developed during the secondary data analysis
included (a) treatment/technology and quality, (b) fighting terms and hopeful messaging,
and the (c) team approach. I provide detailed secondary data findings in the subsequent
paragraphs.
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The first category, established during the secondary data review, included
treatment, technology, and quality. I observed descriptive marketing terms to promote the
treatment options, skill, or quality of care offered at the advertising facility. The terms
included advanced, evidenced-based, high-quality, innovative, latest, leading-edge, new
and better, personalized, powerful, progressive, premier, sophisticated, state-of-the-art,
unparalleled, and world class/renowned. There were several combinations of terms
facilities used to establish their expertise that were identified in this category, such as
“Our community of cancer experts provide highly-skilled care and compassionate
support.”
The next category I observed included fighting terms and hopeful messaging,
which included statements to arouse images of successful outcomes. I identified multiple
emotionally charged messages and phrases of hope. For example, one facility included
the phrase: “Cancer doesn’t have to stop you.” Additional fighting terms identified
included battle, beat, cure, fight, hope, or mobilize, with phrases, such as “We all can
beat cancer,” or “Once you choose hope anything is possible.”
The third category observed was team approach. Phrases associated with team
work included messaging that reflected communicating, collaborating, and helping in the
fight, such as “You are not alone,” or “We’re here to help.” Additional examples of
messaging included being here, working together, or helping “you and your family
through the entire cancer journey.” Other messaging observed in this category included
statements of help, not being alone, support, or being together. Phrases included staff that
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was “dedicated to the principle of complete care for people with cancer and their loved
ones.”
The final category, I observed during the secondary data review, was the physical
environment of care. Facilities used messaging to advertise the physical environment,
such as an “environment that promotes healing,” which included phrases that suggested
the facility could promote calm and decrease stress. Additional examples included the
promotion of healing or healing environments. Facilities were also described as being
designed to simplify or ease the process, such as “We have carefully designed our cancer
centers to simplify and ease the process.”
Evidence of Trustworthiness
Credibility
I used participant in-person interviews, follow-up calls, and literature review as
triangulation methods. I held in-person interviews in neutral locations at the preference of
participants. In-person interviews facilitated episodic-memory, along with prolonged
contact and the follow-up call. Prolonged contact with the data through multiple reviews
led to meeting data saturation.
As recommended by the expert panel, I completed member checking using
interview strategy. I re-asked questions requiring more clarity during the interview or
during the follow-up call. I transcribed the interviews prior to the follow-up call, and any
questions identified during transcription were asked at the time of the follow-up call.
In addition, reflexivity is vital for research credibility. Researchers should
understand and recognize personal biases, as well as the potential influence this could
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have on scientific rigor (Probst, 2015). Credibility for the study findings included
repeated committee work and personal sessions with the committee chair. The
“continuous process of self-reflection” fostered during committee work and personal
researcher preparation also increased credibility (Darawsheh, 2014).
Transferability
The focus of transferability or generalization involved predicting patterns, as
suggested by a researcher (Saldaña, 2016). Prolonged contact with interview audio
recordings, transcripts, and secondary data was completed. The extensive time spent with
participants and reviewing data facilitated transferability. After multiple sessions of hand
coding, categorizations, and thematic analysis, I achieved generalizability.
Dependability
I closely followed the research plan for this study to increase the dependability of
study results. I developed audit trails using tables and other documents created during the
collection, review, analysis of interviews, follow-up calls, and secondary data review.
Researchers could then easily audit the study purpose, participant selection process, data
collection, length of study, detailed analysis, and decision-making processes.
Confirmability
I captured all interview transcripts and follow-up call in one document for each
participant. All notes, developed during the hand coding and thematic analysis, including
coding approach, tables, and other notes, were retained. The literature review indicated
variables that I used for reference only during the initial review of study findings. I
developed the codes, categories, and overall themes organically from the data. I
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highlighted codes clearly associated with literature review identified variables for rereview.
I completed the process of analyzing participant interviews using several phases
of hand coding. I reviewed audio interviews and transcripts multiple times. With each
review of audio or transcript material, the codes were reviewed, new codes added, or
previous codes modified. I then moved codes into categories and used these for theming
activities. The phases of the coding process were detailed in the data analysis section,
which included three phases. All portions on the coding, categories, and themes were
captured on sheets that could be used for study auditing to increase the confirmability of
study findings.
Summary
The conflict between emotion and cognition during decision-making for people
diagnosed with cancer varied for every individual. Using the theoretical framework of
FTT, this study was designed to fill a gap in the current literature. Scholarly research
allowed greater understanding of the decision-making needs and promoted scientific rigor
and generalizable findings.
In this chapter, I consolidated and analyzed the transcribed interviews. Using
hand coding, I developed categories and completed the thematic process. Three
overarching categories emerged that included family/social dynamics, psychological
needs, and decision-making. In addition, I analyzed interviews for existence of FTT
(verbatim and gist recall). I completed a secondary data review that focused on evaluating
the language used in web domains of cancer centers in California.
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The next chapter will include the discussion, conclusions, and recommendations
from this study. Related peer reviewed literature findings will be introduced, along with
the study findings in Chapter 5. The identified unique patient variables will be presented
and the influence on decision-making detailed.
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Chapter 5: Discussion, Conclusions, and Recommendations
The continuum of care, from diagnosis to treatment decision-making, is dynamic
and evolving. The increasing complexity of cancer treatment decision-making is fueled
by continued breakthroughs in research, changes in reimbursement, sicker patients, and
an aging population. The focus for this study was to further scholarly research into the
understanding of participant identified factors that influenced the treatment decisionmaking process.
The study was designed using FTT, a dual process for decision-making. FTT
focuses on the conflict between cognition and emotion. With FTT, the focus results in
verbatim and gist memory recall. There is a need for a greater understanding of how
individuals organize, synthesize, and recall information for cancer treatment decisionmaking, as identified in the literature by Reyna et al. (2015). This case study included
interview findings from 10 participants with a first diagnosis of cancer. Using openended questions, participants told stories of their cancer decision-making journey.
When asked about their journeys, participants did not automatically include
detailed specifics of their diagnosis. Rather, most participant responses included details
of the components of their lives that cancer disrupted. Most of the participants’ feedback
focused on the areas of family/social dynamics, psychological needs, and diagnoses and
treatment decision-making factors. During this profound time of cognizant disruption,
were expected to make sound and well understood decisions, with possible lifelong
implications. Participants wanted to, themselves or through loved ones, understand the
extent of their diagnoses and treatment options.
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Interpretation of Findings
Family/Social Dynamics
Every participant reported family/social dynamics using a variety of illustrations.
The range of experiences varied from supportive to causing added stress, pressure, or
unease. Interpretations of participant responses included loss of privacy, family tension,
and unsolicited input, as provided in this section. This theme was supported through
literature review findings by multiple researchers (Bodie et al., 2011; Epstein &
Gramling, 2013; Feng & Magen, 2015; Imber-Black, 2014).
Supportive. Within the theme of family/social dynamics, I observed participant
responses that indicated gratitude for various offerings of emotional, spiritual, and other
types of support. P4 shared, “They have stood by me at every appointment and
everything that is connected with this disease.” P2 added, “I have a great group of girls to
carry me.” In addition, I located literature review that supported the interview findings of
individuals diagnosed with cancer benefiting from the support of their individual circles
and other communities, including places of work (Kroenke et al., 2013; Trudeau-Hern &
Daneshpour, 2012). Moreover, findings in the literature showed individuals needing and
even relying on the support of others (Lillie et al., 2014; Shin et al., 2013; Tallman,
2013). Other researchers suggested the quality of the support messaging, as well as the
size of the support system is important (Lutgendorf & Anderson, 2015).
Additional stress, pressure, or unease. Participant responses were interpreted
for the category of additional stress, pressure, or unease. Illustrations by participants
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included descriptions of the loss of privacy, preexisting family tensions, and unsolicited
input. This category was primarily the description of the behavior of others.
Participants described the loss of privacy or levels of control of personal
boundaries. P5 stated, “Your dignity goes out the window.” Joseph-Williams et al.’s
(2014) research showed support for complaints of lack of privacy in the health care
setting. For some participants, too much attention or other boundary infractions were not
what they wanted or were comfortable with. P3 expressed, “All of the sudden everybody
wants to take care of you. Also, I am just the opposite.” Participants were sensitive to the
feeling of others and did not turn people away. However, the lack of boundaries caused
the participants additional stress. I also identified some literature about the overstepping
of caregiver boundaries, not the boundaries of patients (see Trudeau-Hern & Daneshpour,
2012).
Tenuous or strained family relationships prior to the diagnosis of cancer fostered
additional stress for some participants. P1 stated, “My [family] showed up. Also, I was
like, “What the heck are they doing here?” I am not close to my family. Never been really
close to my [family]… The day I was diagnosed, they showed up.” This preexisting stress
made navigating family conversations more difficult for participants. Imber-Black (2014)
highlighted the challenges families faced when they were not equipped to have
discussions related to chronic life-threatening illnesses. Families not equipped to have
these discussions could do more harm to participants and to relationships (Feng &
Magen, 2015; Imber-Black, 2014; Lutgendorf & Andersen, 2015). Imber-Black (2014)
included illustrations of the presence and influence of unaddressed issues within family
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or social relationships. Imber-Black’s research also showed examples of questions to aide
in family discussions.
Descriptions of increased stress when unsolicited input was encountered were
provided by participants. P1 shared, “This relative kept comparing my treatment to
[theirs]. …[they] would say why are they doing that? My doctor didn’t do that. Or why
didn’t they do this because my doctor did? You need to get a new doctor.” Expressions of
self-doubt were detailed when participants faced continued unsolicited input. P1
reflected, “I am second guessing my decisions on my life… [they] put doubts in my
head.” Feng and Magen (2015) conducted research on the presence of unsolicited advice
and relational closeness. Feng and Magen (2015) suggested that unsolicited advice, when
not given in a “skillful” way can be harmful (p. 13).
Psychological/Emotional Distress
According to the NCI (2012), psychological stress can “reduce the quality of life
of cancer patients” (para. 2). In this section, I provide detailed interpretations of the
themes that developed based on the psychological or emotional distress reported by the
participants. I located terms related to emotional or psychological distress in many cancer
related literature reviews (Clarke et al., 2015; Leonarczyk & Mawn, 2015; NCI, 2012;
Tevaarwerk et al., 2016; Siegel et al., 2012; Tallman, 2013). The categories included (a)
shock, confusion, or fear; (b) emotional distress/fatigue; and (c) other feelings of guilt
and participant identified psychological needs.
Shock, confusion, or fear. Participants detailed shock, confusion, and fear at and
immediately following their diagnoses. P8 expressed, “It couldn’t be real.” Participants
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also detailed being confused or the inability to concentrate. P5 stated, “I made at least
four wrong turns on the way home. I just sat in the parking lot for a while.” P2 said, “I
felt like it was a black tar going in to my brain.” Trudeau-Hern and Daneshpour (2012)
spoke of the emotional journey that included “feeling overwhelmed, isolated, exhausted,
and disconnected” (p. 543). Multiple articles, found in the literature, showed support for
responses to the traumatic experience of a diagnosis of cancer. Literature findings
indicated the complexity and overwhelming nature of this diagnosis (Epstein &
Gramling, 2013; Gibbins et al., 2014; Livaudais et al., 2013; Moore, 2014). Jacobsen and
Andrykowski (2015) also reinforced the idea of the presence of heightened levels of
anxiety during the period surrounding diagnoses and early decision-making processes.
Fear was also described as long-term. Participants expressed their concern for
what would happen after treatment. P5 shared, “Even after you are done with treatment
it’s there. It’s like it will be there forever.” Other researchers have detailed the
importance of considering and addressing psychological needs for patients after
treatment. For example, Imber-Black (2104) noted potential emotional reactions to
anniversaries of illness and potential changes in family rituals due to illness. Stanton et al.
(2015) suggested that there had not been attention given to the potential effects and longterm costs associated with the psychological or physiological conditions that patients
endured after treatment. Cognitive dysfunction can be caused by treatment, as in the case
of chemotherapy or chemo-brain (Green McDonald, O’Connell, & Suls, 2015; Moore,
2014). However, the cognitive dysfunction can occur or be exacerbated by tension, lack
of sleep, or other factors (Moore, 2014).
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Emotional distress/fatigue. I observed increasingly pronounced descriptions
from participants of emotional distress that was more prominent compared to in the
previous category. My interpretation of the interview findings for this section included
analyzing the emotional toll experienced by participants when they told others, especially
children, about their diagnoses. I provided an analysis of the psychological influence
from treatment side effects and participant identified feelings of guilt and unmet
psychological needs.
Emotional distress was described when participants had to tell others of their
diagnosis of cancer. Increasing levels of worry were detailed when children were
involved; for example, P4 stated, “I don’t want to scare them,” P2 added, “I was freaking
out about telling my kids,” and P5 shared, “I found out it was [Stage] II, and I never told
them. It’s just, I did not want their world to be chaotic more than it had to be.” I observed
statements of emotional fatigue during the interview process and found four of the 10
participants included some reference to emotional fatigue. The frequency of reported
emotional distress or emotional fatigue was also well supported in the literature (ASCO,
2015; Green McDonald et al., 2015; Jacobsen & Andrykowski, 2015; Siegel et al., 2012;
Tevaarwerk et al., 2016). I also identified literature that included findings that individuals
diagnosed with cancer became increasingly anxious as the end of treatment approached
and less interaction with their oncologist was expected (Jacobsen & Andrykowski, 2015).
Leading organizations in oncology have published extensively on the need for increased
attention in support for emotional distress in patients diagnosed with cancer (ASCO,
2015; Green McDonald et al., 2015).
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Examples of agonizing pain due to side effects of treatment were followed by
statements of participants wanting to quit treatment or more severe. P10 stated, “I am
practically suicidal I am in such pain.” Previous research findings showed the prevalence
of individuals diagnosed with cancer, and experiencing significant pain was as high as
33% (Dy et al., 2014; Jacobsen & Andrykowski, 2015). The psychological influence of
intractable pain was also supported in the literature (Cella & Stone, 2015; IOM, 2013).
Glass et al. (2012) also recognized pain in research that developed questions for providers
to use in deciding pain control options with patients. Extreme stress is also known to have
physiological implications, even including disease progression (Lutgendorf & Anderson,
2012; NCI, 2012).
Other feelings of guilt and participant identified psychological need. I
observed statements of guilt from participants. For instance, variations of survivor guilt
were described. P2 asked, “I am happy to be alive but how come I got the pass?”
Participants noted that support groups could initiate guilt or other feelings of distress
from the constant reminder of cancer. P5 shared, “There [are] like 2,000 members. Also,
I am starting to feel a little down.” I located literature that supported participant
suggestions of additional stress from support groups, as well as guilt associated with
more favorable outcomes compared to what others have endured (Burg et al., 2015;
Green, Wodajo, Yang, Sleven, & Pieters, 2017).
One participant out of 10 interviewed received a formal referral to a psychologist.
The referral to the psychologist came after the participant made the request. Asking
participants if they would have benefited from psychological support was not part of the
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study design. However, Croyle (2015) completed a literature analysis of research specific
to the contributions of psychology in comprehensive cancer treatment. Studies showed
support for reporting unmet psychological needs and an increase in psychological distress
after treatment was completed (Burg et al., 2015; Cella & Stone, 2015; Stanton et al.,
2015). In addition, screening for psychological needs was reported in the literature as an
important component of comprehensive cancer care (ASCO, 2015; Green McDonald et
al., 2015; Trudeau-Hern & Daneshpour, 2012).
Decision-Making
The final theme to be interpreted and presented is decision-making. Decisionmaking is influenced by the many themes presented in this research. In this section, I
explain the following categories identified for decision-making: (a) being influenced by
experience of cancer in others, (b) avoidance, and (c) selection of treatment locations.
This theme rounded out the findings specific to decision-making from interview
responses for this study.
SDM and patient directed care examples were provided in Chapter 4. Participants
described the use of SDM with their providers and complemented the communication of
the cancer team. For example, P1 stated, “My appointment was 2 and a half hours long.
Then another hour with the [navigator]… [the doctor said] you have three options that
you need to think about.” P2 said, “I made the decision that night… they never made me
feel like I was making a wrong decision.” A significant volume of literature regarding
SDM was reviewed during the preparation of the study proposal. The SDM literature
suggested that many providers were not consistently communicating with patients and
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were not using SDM skills (Back et al., 2014; daCosta DiBonaventura et al., 2014;
Epstein & Gramling, 2013; Glass et al., 2012; Joseph-Williams et al., 2014; Livaudais et
al., 2013; Pass et al, 2012; Thorne, Oliffe, Stajduhar, Oglov et al., 2013). There were no
statements provided by participants to support framing or other types of provider
messaging that influenced the participants (Back et al., 2014; Broniatowski & Reyna,
2013; Epstein & Gramling, 2013)
Participants also described leaving current providers to find someone they felt
more comfortable with. For instance, P10 shared, “I found a doctor that I felt I could
work with better… it was oh so much a more agreeable plan to me.” P6 also stated, “I
went out of network, paid out of pocket to see another doctor to try and get someone
else’s feedback on it. Because I felt like I was getting the run around.” I identified
literature that showed support for the issues associated with disagreements between
patients and providers, as well as the potential negative influence this could have on
overall care (Kane, Halpern, Squiers, Treiman, & McCormack, 2014).
Influenced by experience from cancer in others. Experience with cancer in
others was detailed as influencing decision-making for some participants. Participants
detailed the influences that occurred when they witnessed unfavorable outcomes. This
aspect led to decision-making requests for more treatment or less treatment compared to
what providers recommended. For example, P2 asserted, “I am going to be aggressive. I
don’t care.” Requests for less treatment were also described, as P10 claimed, “It [the
radiation] eventually killed him.” P3 also shared, “It was supposed to give her a better
quality of life… which neither one of us could see.” Literature findings showed the
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influence of past experiences with cancer on patient decision-making and the willingness
of patients to endure the side effects of aggressive treatment (Gibbins et al., 2014; ImberBlack, 2014).
Avoidance. Participants described delegating roles to others during the decisionmaking process. P2 said, “I didn’t want to really know.” P4 added, “It isn’t that I am
sticking my head in the sand, it is just that in my heart and in my soul, I really don’t feel
the need to have to dig in to all of that.” I located literature that showed support for the
participant responses of wanting to delegate responsibility of treatment decisions (Back et
al., 2014; Livaudais et al., 2013; Pass et al., 2012). Researchers have also noted that not
all patients were comfortable with the responsibility of decision-making, feeling
overwhelmed or burdened with the responsibility (Back et al., 2014; Livaudais et al.,
2013; Pass et al., 2012). The literature review findings showed more study results that
reflected a reliance on others to help navigate the information overload. This reliance on
others differed from statements of avoidance reflected in the current study findings.
Literature review findings that showed support for SDM and the benefits of receiving
treatment information when patient support members were more prominent (Lillie et al.,
2014; Shay & Lafata, 2015).
Selection of treatment locations. All participants stated they were directed to the
treatment locations by the insurance company. Participants also reflected on their
satisfaction or dissatisfaction with referral process. One participant left his or her
community to seek treatment. He or she reported leaving due to mistrust of the medical
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providers. Livaudais et al. (2013) included a reflection of mistrust of the medical
profession, which one participant demonstrated:
I went out of network, paid out of pocket to see another doctor to try and get
someone else’s feedback on it. Because I felt like I was getting the run around.
After hitting all these brick walls, I said, I am going to pay the out of pocket costs
and go to a doctor that is not governed by the insurances and that they still hold
value in their Hippocratic oath, and I am glad that I did. (P7)
Researchers have suggested underlying cultural differences influencing the selection of
treatment location, not asked in this study (Joseph-Williams et al., 2014; Livaudais et al.,
2013; Singh et al., 2010).
Dual Process (FTT)
FTT consists of the combination of verbatim recall, gist recall, and the conflict
between the two (Reyna et al., 2015). This section provides the interpretation of
participant verbatim and gist recall associated with FTT. The participant responses to the
interview question about the influence of emotion or information on their decisionmaking process is provided within this section.
All participants offered recall of their cancer stage. The responses could be
considered verbatim: “[The lymph nodes] were clear. My understanding is that is next to
nothing” (P4). Participant statements also showed areas of incomplete understanding
after treatments were decided and begun: “Some things [were]… skimmed over” (P3).
Understanding of pain control is another area of misunderstanding: “No one told
me that you need to take the pain meds before” (P10). P1 commented, “I never knew…
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the medicines have all kinds of different effects.” It was unclear if any of the responses
represented rote memorization.
Verbatim recall refers to detailed information, made up of complex concepts
including survival statistics, risk ratios, or percentages for treatment success (Reyna et al.,
2015; Smith et al., 2013). Gist recall is also referred to as the fuzzy portion of decisionmaking. Gist recall develops from unconscious awareness or individual perception, and
represents vague or qualitative concepts (Reyna et al., 2015; Smith et al., 2013). My
observations and interpretations of participant responses included a lack of focus on the
specifics of the diagnosis. Participants responded with greater emphasis on how cancer
impacted their lives. Recent FTT research was published in 2016 that indicated the
existence of false memories associated with complex decision-making (Reyna, Corbin,
Weldon, & Brainerd, 2016). When verbatim recall was not offered, questions were reasked, but participants were not pressed to remember specifics to avoid unintended
distress.
I overserved participant interview responses that placed greater emphasis on the
weight of emotions versus information during decision-making. P1 stated, “So, I could be
here for my kids.” In addition, P3 stated, “What I have been through with my wife and
kids” as being more influential to decision-making. I also observed participants detailing
a combination of emotion and information as influential to treatment decision-making.
For example, P2 stated, “Emotionally driven… [with] some real statistics.” P4 stated,
“It’s a mesh.” In two participants, information was more influential in their decision-

93
making. P6 stated, “If we let our emotions take over, we don’t always make the best
decision.”
Cancer Advertising and DTCA
The interpretation of the participant interview responses, regarding cancer
advertising and the secondary data review, are provided in this section. Recall by
participants about cancer advertising suggested participants were not aware or did not
draw from previous DTCA exposure. Participants suggested sensitivity to cancer
advertising increased only after their diagnosis: “Before I had cancer, I didn’t pay
attention” (P4). P1 commented, “[We] would sit laughing because it seemed like as soon
as I was diagnosed every other commercial is cancer treatment.” The literature review for
DTCA and marketing of cancer services showed examples of mass media or fame could
influence medical decision-making (Lebo et al., 2015). In addition, I found research that
was specific to exposure to DTCA and the potential influence of DTCA exposure (Abel
et al., 2009; Tan, 2015). Abel et al. (2009) suggested that increases in TV were correlated
with increased exposure in DTCA. Abel et al. also suggested that there were no
significant changes in therapy options for participants, as being caused by DTCA.
Some participants responded unfavorably to cancer advertising: “Every other
commercial on TV which I am so sick of looking at TV I don’t even turn it on anymore”
(P4). P8 stated the following:
We started seeing a lot of these commercials “if you want to live longer,” and we
thought that was in very poor taste. That type of advertising… we thought it was
in really poor taste. It is more of a scare in our opinion.
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Vater et al. (2014) suggested the increased use of “emotional appeals that evoke hope and
fear” (p. 818) in DTCA by cancer centers.
DTCA. The categories that developed during the secondary data analysis of
cancer advertising are presented in Chapter 4. The categories include treatment,
technology, and quality; fighting terms and hopeful messaging; team approach; and
physical environment. The overall interpretation of the secondary data review follows the
categories at the end.
Advertising statements, regarding treatment, technology, and quality, focused on
promoting the services offered by the advertising facility. These included the following:
(a) “Our unique blend of cancer research and patient care results in new and better
treatment options” and (b) “our state-of-the-art diagnostic capabilities and leading-edge
treatment options.” Vater et al. (2014) included findings that supported the promotion of
services. Vater et al. furthered that the promotional advertising only noted the benefits of
their services. Vater et al. also noted potential risks with treatment, alternative options, or
insurance coverage were not included in the advertisements.
Fighting terms and hopeful messaging are abundant in the advertising data
analysis. The prominent terms identified in this category included fight or fighting, beat,
and cure. In addition, I identified words of hope, compassion, and well-being. Vater et al.
(2014) focused on a proliferation of “emotional appeals.” Hope was also a prominent
finding in Vater et al.’s research. Other researchers have shown an interest in studying the
impact of hopeful messages for individuals diagnosed with cancer (Schapmire et al.,
2012).
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The next category contained terms associated with team work. Examples included
the following: (a) “Working together we’ll find the answer;” (b) “we encourage and
promote communication;” and (c) “decide together on the best course for each patient.”
The terms prominent in this section were also prominent in the literature identified for
SDM and other patient directed decision-making literature (Elwyn et al., 2014). Vater et
al. (2014) identified this type of advertising strategy in their research. In the Vater et al.
research, terms related to team work were included in the advertisement of services.
The final category includes the physical environment. This is a small segment of
the secondary data analysis. Examples include the following: (a) “We have carefully
designed our cancer centers to simplify and ease the process,” and (b) “in an environment
that promotes healing.” Vater et al. (2014) identified this type of advertising strategy in
their research. In the Vater et al. research, terms related to environment were included in
the advertisement of services.
I could not make correlations between participant recollection and cancer
advertising, which was not the focus of this study. Literature findings showed that cancer
advertising lacked regulatory oversight, such as the regulations imposed on
pharmaceutical advertising (Schenker et al., 2014; Tan, 2015; Vater et al., 2014). Tan
(2015) and Vater et al. (2014) suggested DTCA was controversial and focused on using
messages to stir up emotions to influence treatment decision-making. Literature suggests
a continued use of ambiguous wording and lack factual support in advertising statements
(Schenker et al., 2014; Vater et al., 2014).
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Limitations of the Study
The study protocol for data trustworthiness were closely adhered to as designed. I
followed structures for credibility, transferability, dependability, and confirmability. I
used member checking, prolonged contact with the data, audit trails, and hand coding,
respectively. This section will provide the study limitations.
The recruitment strategy was a limitation. Collaborating with one or more
community based cancer centers would have been a better approach. The daunting and
lengthy task of IRB approval should have been attempted for this study. Recruitment
using the originally designed methods was extremely time consuming to produce the
needed participant counts.
The review of DTCA required modification from the original study plan. I
removed pamphlets and newspaper advertisements as secondary data materials. Asking
participants to track the frequency of their exposure to DTCA could have been beneficial.
Recommendations
Interview findings showed that the decision-making life-cycle after a diagnosis of
cancer was a far more dynamic and chaotic experience. Participant interviews proved the
cancer journey focused more on how the disease influenced the lives of individuals and
their support circles. Research findings also indicated the assumptions that the patient
support circles and previous experiences with cancer in others provided a substantial
influence on patient decision-making.
Continued scholarly research, focused on defining factors that influence decisionmaking after a life-threatening diagnosis, are warranted. Examples of additional research
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can include recurring clinic based research interviews. Real-time interviews may allow
individuals to identify the complex and evolving needs across the continuum of care.
Most participants detailed unmet psychological support. The area of psychooncology was not the specific focus for this study. The significance for assessing and
meeting the psychological needs of participants go beyond the emotional influence and
have physiological implications, as represented in oncology literature (DellaRipa et al.,
2015; Lutgendorf & Andersen, 2015). Further research in understanding the roadblocks
or challenges individuals face in receiving needed psychological support is significant.
Researching the existence or absence of psychological distance is also
recommended. Two sets of researchers alluded to the potential influence of psychological
distance on decision-making (Aning et al., 2012; Fukukura et al., 2013). Due to the
amount of psychosocial distress experienced after a diagnosis of cancer, it would be
beneficial to evaluate the benefits of psychological distance in cancer treatment decisionmaking.
Implications
Few statements have the power to strike fear in to the hearts of individuals, as the
three words: “You have cancer.” This research can create positive social change through
the advancement of scientifically validated research focused on supporting patients
during the decision-making process. Oncology health care professionals and health care
leaders can use the findings and recommendations during programmatic development to
ensure patient centric approaches to decision-making.
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The unique individual needs and resources for each patient creates an exceptional
challenge for health care professionals. As the current research shows, the decisionmaking process is influenced by more than what occurs within the walls and
conversations of healthcare providers. Psychological stress, family or social pressures,
and other needs influence patient decisions and behavior. One may use the findings and
recommendations from this study to show areas where additional studies can bring about
added positive social change.
Conclusion
In the process of delivering cancer care, health care teams must embrace all
diverse and complex patient needs. The delivery of healthcare is in crisis, and cancer care
teams face deciding way in which to meet these needs, in some instances, with limited
resources. The evolution of comprehensive cancer teams is a strategic opportunity to find
successful solutions to meet these diverse needs. Teams should include providers trained
in the psychological component of the diagnosis of cancer as a compliment to the support
of physicians, nurses, and other allied health. Research continues to evolve the
understanding of ways in which individuals organize, synthesize, and recall information.
This inclusion of behavioral specialist or oncologic psychologists, as an expected part of
the cancer team, is in the best interest of patients and families during such a trying time.
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Appendix A: Advertisement Flyer Language #1
A research study opportunity is available that is focused on developing a deeper
understanding of the treatment decision making experiences for patients newly diagnosed
with cancer. You are invited to take part or share this information with someone you
know.
Criteria for Participation
•

Adults, ages 25-80 without cognitive impairment

•

Living in California at the time of diagnosis

•

Without a previous diagnosis of cancer

Benefits of participating in research
• You can help researchers provide detailed findings that can help future
patients diagnosed with cancer navigate the decision making
•

Findings can also provide the healthcare industry with opportunities to
develop patient centered best practices for decision making.

For more information about participating in this research please contact the research
at XXX@waldenu.edu or call XXX
Or find research specific on the following social media sites:

https://www.facebook.com
https://www.linkedin.com
@
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Appendix B: Interview Protocol
Thank you for your agreeing to participate and for taking the time to allow me to
interview you today.
As we reviewed in the consent, I will be audio recording the interview.
I might take notes on my clip board while you are speaking to help me keep track
of follow-up questions.
The confidentiality of any notes will be protected at the same level as all of the
data.
We have planned this interview to last no longer than one hour.
If it looks like we will run short on time, I will ask you if you would like to extend
the interview time before proceeding.
Just a reminder, the interview can be stopped at any time.
Do you have any questions before we get started?
Interview Questions, Section I
1. Interview Part 11. Starting with the day you found out you had cancer, tell me everything
you can remember about your experience.
i. Sub-questions to facilitate the discussion:
1. Tell me anything you remember about the information your
provider(s) shared with you about your diagnosis.
2. Tell me anything you remember about the treatment
information your provider(s) shared with you.
2. If you took others with you when you received your cancer diagnosis tell
me about the experience.
3. Tell me about your experience discussing your personal health beliefs or
individual values with your provider.
i. Sub-questions to facilitate the discussion:
1. Tell me what you remember about discussing treatment
options.
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2.

Tell me what you remember about any questions your
provider(s) asked about your personal beliefs.

4. In the days immediately following your diagnosis, tell me anything you
can remember about steps you took to help you understand your diagnosis:
i. Sub-questions to facilitate the discussion:
1. For instance, what steps did you take to research your
diagnosis?
5. Tell me about the reactions or responses from your family or other
members of your support circle when they found out about your diagnosis.
6. Tell me about any members of your family or support circle that you did
not want to tell about your diagnosis, and why?
7. Tell me anything you can remember about discussions you had about your
personal wishes for treatment. Maybe spiritual or cultural beliefs?
8. Tell me about anyone outside of your family and friends that you spoke to
about your diagnosis.
9.

Tell me about any experiences you had with calling a help line, or
attending support programs.

10. Share with me your experience with selecting the location to receive your
treatment?
i.

Sub-questions to facilitate the discussion:
1. How did you decide on which providers to see or facilities
to go to?
2. How many facilities did you consider before deciding
where to go for treatment?

11. Tell me about any second opinions or other providers you spoke with
before deciding on a treatment plan.
2. Interview Part II1. Prior to your diagnosis of cancer, tell me about any experiences you had
with cancer;
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i. Sub-questions to facilitate the discussion:
1. Tell me about family members or friend that had with
cancer.
2. Tell me about any experience you have had as a care giver
for a someone diagnosed with cancer?
3. Tell me how you think your past experiences with cancer
influenced your cancer decision making.
2. Tell me about any anything you can remember about cancer related
advertising.
i. Sub-questions to facilitate the discussion:
1. Tell me about any advertising for cancer facilities or
treatments you can recall.
3. Tell me what you remember about your cancer stage.
3. Interview Part III- other
1. In the previous section we discussed your experience when you learned
about your diagnosis of cancer. We also discussed your experiences with
cancer prior to your diagnosis.
2. Is there anything you feel we have not discussed and you would like to
share with me about your journey?
3. My last question. During the period of treatment decision making we have
been discussing, which do you believe provided greater influence,
information or emotion?
4. Journal Notes, Section IV1. I am providing you with a journal that was detailed in the consent.
2. Please journal any experiences related to your cancer journey in any way.
3. There are no directions or rules for journaling.
4. Include anything you wish to share.
5. Select option for collection of journal (one option please):
Researcher will personally pick up the journal from you.
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Journal notes will be scanned and sent electronically via an email.
The journal will be returned via mail in a double envelope and postage
paid.
5. Follow-up Call, Section V1. Can we schedule the follow-up call now?
i. If you need to look at your schedule, how would you like me to
reach you to schedule?
1. Date: __________________
2. Time: __________________
If you need to reschedule the follow-up call, please email me at
XXX@waldenu.edu
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Appendix C: Advertisement Flyer Language #2
Request for Participation. Tell you story, Share your journey. Contribute to
research for the future. Recruiting volunteers to join a research study focused on the
journey of participants newly diagnosed with cancer.
Background, purpose, and benefits of participation:
•

The objective of the study is to contribute to the growing body of
scientifically validated research surrounding the decision-making process, and
to strive to understand and meet the evolving needs of patients diagnosed with
cancer.

•

Your participation can help future patients diagnosed with cancer navigate the
decision-making journey.

•

Research results can also provide the healthcare industry with opportunities to
develop patient centered best practices for decision making.

Criteria for Participation:
•

Adults, ages 25-80, without cognitive impairment

•

Living in California at the time of diagnosis

•

Without a previous diagnosis of cancer.

Participation Activities:
•

One interview (scheduled)

•

Personal journaling

•

One Follow-up call (30-45 days after interview)
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Study information can be obtained by contacting the researcher and on the following
sites:
•

American Cancer Society- Cancer Survivors Network http://csn.cancer.org

•

Facebook https://www.facebook.com

•

LinkedIn https://www.linkedin.com

•

Twitter

Contact the researcher Bonnie Quinonez at XXX@waldenu.edu or, by calling XXX
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Appendix D: Cancer Advertising - List of Facilities
Facility/Organization Name
AIS Cancer Center
Mercy General
Beverly Hills Cancer Center
Methodist Hospital
California Cancer Center
Orange Coast Memorial Medical Center
California Oncology Central Valley
PIH Health Hospital - Whittier
Cancer Center of Southern California
Providence Holy Cross Medical Center
Cancer Treatment Center Anaheim
Queen of the Valley Medical Center
Cedars Sinai
Redding Cancer Treatment Center
City of Hope (Antelope Valley, Santa
Saint Johns health center
Clarita, Simi Valley, Duarte, Pasadena)
Community Hospital of the Monterrey
Saint Josephs
Peninsula
Cypress Women’s Cancer Treatment
Saint Jude medical center
Center
Eisenhower Medical Center
Santa Barbara cottage hospital
El Camino Medical Center
Scripps
Glendale Adventist
Sharp Mary Birch Hospital
Hoag Family Cancer Institute
Sharps Chula vista
Huntington Hospital
Sierra View
John Muir Concord
Stanford
John Muir Walnut Creek
Sutter Roseville
John Wayne Cancer Institute
Torrance Memorial Medical Center
Kaiser - Roseville
UC Davis
UC Irvine Health Chao Family
Kaiser - Santa Clara
Comprehensive Cancer Center
Loma Linda Cancer Center
UC San Diego Moores Cancer Center
Long Beach Memorial
UCLA Medical Center
Marian Regional Medical Center
UCSF Medical Center
Memorial Medical Center

USC Norris Cancer Hospital-Keck Medical
Center of USC

